-
2
-
-
84862276328
-
Structure, function and diversity of the healthy human microbiome
-
[2] Huttenhower, C., Gevers, D., Structure, function and diversity of the healthy human microbiome. Nature 486 (2012), 207–214.
-
(2012)
Nature
, vol.486
, pp. 207-214
-
-
Huttenhower, C.1
Gevers, D.2
-
3
-
-
84879234708
-
Analysis of the human gut microbiome and association with disease
-
[3] Wu, G.D., Lewis, J.D., Analysis of the human gut microbiome and association with disease. Clin. Gastroenterol. Hepatol. 11 (2013), 774–777.
-
(2013)
Clin. Gastroenterol. Hepatol.
, vol.11
, pp. 774-777
-
-
Wu, G.D.1
Lewis, J.D.2
-
4
-
-
84905235179
-
Gut microbiota: the neglected endocrine organ
-
[4] Clarke, G., Stilling, R.M., Kennedy, P.J., Stanton, C., Cryan, J.F., Dinan, T.G., Gut microbiota: the neglected endocrine organ. Mol. Endocrinol. 28 (2014), 1221–1238.
-
(2014)
Mol. Endocrinol.
, vol.28
, pp. 1221-1238
-
-
Clarke, G.1
Stilling, R.M.2
Kennedy, P.J.3
Stanton, C.4
Cryan, J.F.5
Dinan, T.G.6
-
5
-
-
84897138296
-
Hand, role of the microbiota in immunity and inflammation
-
[5] Belkaid, Y., Timothy, W., Hand, role of the microbiota in immunity and inflammation. Cell 157 (2014), 121–141.
-
(2014)
Cell
, vol.157
, pp. 121-141
-
-
Belkaid, Y.1
Timothy, W.2
-
6
-
-
0004147167
-
The Prolongation of Life: Optimistic Studies
-
Putnam's Sons New York
-
[6] Metchnikoff, E., The Prolongation of Life: Optimistic Studies. 1908, Putnam's Sons, New York.
-
(1908)
-
-
Metchnikoff, E.1
-
7
-
-
84883122879
-
The promise of poop
-
[7] de Vrieze, J., The promise of poop. Science 341 (2013), 954–957.
-
(2013)
Science
, vol.341
, pp. 954-957
-
-
de Vrieze, J.1
-
8
-
-
84930278586
-
The trendy microbes
-
[8] Viswanathan, V.K., The trendy microbes. Gut Microbes 5 (2014), 439–440.
-
(2014)
Gut Microbes
, vol.5
, pp. 439-440
-
-
Viswanathan, V.K.1
-
9
-
-
33747141012
-
The use of clostridial spores for cancer treatment
-
[9] Barbé, S., Van Mellaert, L., Anné, J., The use of clostridial spores for cancer treatment. J. Appl. Microbiol. 101 (2006), 571–578.
-
(2006)
J. Appl. Microbiol.
, vol.101
, pp. 571-578
-
-
Barbé, S.1
Van Mellaert, L.2
Anné, J.3
-
10
-
-
0003396519
-
The Beneficial Effects of Bacterial Infections on Host Resistance to Cancer: End Result in 449 Cases
-
Cancer research institute New York USA
-
[10] Nauts, H.C., The Beneficial Effects of Bacterial Infections on Host Resistance to Cancer: End Result in 449 Cases. 1980, Cancer research institute New York, USA.
-
(1980)
-
-
Nauts, H.C.1
-
11
-
-
0033126621
-
Coley toxins immunotherapy: a retrospective review
-
[11] Richardson, M.A., Ramirez, T., Russell, N.C., Moye, L.A., Coley toxins immunotherapy: a retrospective review. Altern. Ther. Health Med. 5 (1999), 42–47.
-
(1999)
Altern. Ther. Health Med.
, vol.5
, pp. 42-47
-
-
Richardson, M.A.1
Ramirez, T.2
Russell, N.C.3
Moye, L.A.4
-
12
-
-
23944458657
-
Coley's toxin revisited: immunotherapy or plasminogen activator therapy of cancer?
-
[12] Zacharski, L.R., Sukhatme, V.P., Coley's toxin revisited: immunotherapy or plasminogen activator therapy of cancer?. J. Thromb. Haemost. 3 (2005), 424–427.
-
(2005)
J. Thromb. Haemost.
, vol.3
, pp. 424-427
-
-
Zacharski, L.R.1
Sukhatme, V.P.2
-
13
-
-
33747149297
-
Localization of the vegetative form of Clostridium tetani in mouse tumors following intravenous spore administration
-
[13] Malmgren, R.A., Flanigan, C.C., Localization of the vegetative form of Clostridium tetani in mouse tumors following intravenous spore administration. Cancer Res. 15 (1955), 473–478.
-
(1955)
Cancer Res.
, vol.15
, pp. 473-478
-
-
Malmgren, R.A.1
Flanigan, C.C.2
-
14
-
-
0032144380
-
Colonisation of Clostridium in the body is restricted to hypoxic and necrotic areas of tumours
-
[14] Lambin, P., Theys, J., Landuyt, W., Rijken, P., van der Kogel, A., van der Schueren, E., Hodgkiss, R., Fowler, J., Nuyts, S., de Bruijn, E., Van Mellaert, L., Anné, J., Colonisation of Clostridium in the body is restricted to hypoxic and necrotic areas of tumours. Anaerobe 4 (1998), 183–188.
-
(1998)
Anaerobe
, vol.4
, pp. 183-188
-
-
Lambin, P.1
Theys, J.2
Landuyt, W.3
Rijken, P.4
van der Kogel, A.5
van der Schueren, E.6
Hodgkiss, R.7
Fowler, J.8
Nuyts, S.9
de Bruijn, E.10
Van Mellaert, L.11
Anné, J.12
-
15
-
-
0034032620
-
Bifidobacterium longum as a delivery system for therapy: selective localization and growth in hypoxic tumors
-
[15] Yazawa, K., Fujimori, M., Amano, J., Kano, Y., Taniguchi, S., Bifidobacterium longum as a delivery system for therapy: selective localization and growth in hypoxic tumors. Cancer Gene Ther. 7 (2000), 269–274.
-
(2000)
Cancer Gene Ther.
, vol.7
, pp. 269-274
-
-
Yazawa, K.1
Fujimori, M.2
Amano, J.3
Kano, Y.4
Taniguchi, S.5
-
16
-
-
84930750844
-
Salmonella as an innovative therapeutic antitumor agent
-
[16] Chang, W.W., Lee, C.H., Salmonella as an innovative therapeutic antitumor agent. Int. J. Mol. Sci. 15 (2014), 14546–14554.
-
(2014)
Int. J. Mol. Sci.
, vol.15
, pp. 14546-14554
-
-
Chang, W.W.1
Lee, C.H.2
-
17
-
-
0003170909
-
Oncolysis by Clostridia. II. Experiments on a tumor spectrum
-
[17] Gericke, D., Engelbart, K., Oncolysis by Clostridia. II. Experiments on a tumor spectrum. Cancer Res. 24 (1964), 217–221.
-
(1964)
Cancer Res.
, vol.24
, pp. 217-221
-
-
Gericke, D.1
Engelbart, K.2
-
18
-
-
78651160643
-
Oncolysis by Clostridia. IV. Effect of nonpathogenic clostridial spores
-
[18] Thiele, E.H., Arison, R.N., Boxer, G.E., Oncolysis by Clostridia. IV. Effect of nonpathogenic clostridial spores. Cancer Res. 24 (1964), 234–238.
-
(1964)
Cancer Res.
, vol.24
, pp. 234-238
-
-
Thiele, E.H.1
Arison, R.N.2
Boxer, G.E.3
-
19
-
-
0027077753
-
Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome)
-
[19] Bone, R.C., Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 268 (1992), 3452–3455.
-
(1992)
JAMA
, vol.268
, pp. 3452-3455
-
-
Bone, R.C.1
-
20
-
-
0027528798
-
Anticytokine strategies in the treatment of the systemic inflammatory response syndrome
-
[20] Dinarello, C.A., Gelfand, J.A., Wolff, S.M., Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 269 (1993), 1829–1835.
-
(1993)
JAMA
, vol.269
, pp. 1829-1835
-
-
Dinarello, C.A.1
Gelfand, J.A.2
Wolff, S.M.3
-
21
-
-
0030030428
-
A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide
-
[21] Somerville, J.E. Jr., Cassiano, L., Bainbridge, B., Cunningham, M.D., Darveau, R.P., A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide. J. Clin. Investig. 97 (1996), 359–365.
-
(1996)
J. Clin. Investig.
, vol.97
, pp. 359-365
-
-
Somerville, J.E.1
Cassiano, L.2
Bainbridge, B.3
Cunningham, M.D.4
Darveau, R.P.5
-
22
-
-
15444341308
-
A lethal role for lipid A in Salmonella infections
-
[22] Khan, S.A., Everest, P., Servos, S., Foxwell, N., Zähringer, U., Brade, H., Rietschel, E.T., Dougan, G., Charles, I.G., Maskell, D.J., A lethal role for lipid A in Salmonella infections. Mol. Microbiol. 29 (1998), 571–579.
-
(1998)
Mol. Microbiol.
, vol.29
, pp. 571-579
-
-
Khan, S.A.1
Everest, P.2
Servos, S.3
Foxwell, N.4
Zähringer, U.5
Brade, H.6
Rietschel, E.T.7
Dougan, G.8
Charles, I.G.9
Maskell, D.J.10
-
23
-
-
0032927753
-
Lipid a mutant Salmonella with suppressed virulence and TNFα induction retain tumor-targeting in vivo
-
[23] Low, K.B., Ittensohn, M., Le, T., Platt, J., Sodi, S., Amoss, M., Ash, O., Carmichael, E., Chakraborty, A., Fischer, J., Lin, S.L., Luo, X., Miller, S.I., Zheng, L.M., King, I., Pawelek, J.M., Bermudes, D., Lipid a mutant Salmonella with suppressed virulence and TNFα induction retain tumor-targeting in vivo. Nat. Biotechnol. 17 (1999), 37–41.
-
(1999)
Nat. Biotechnol.
, vol.17
, pp. 37-41
-
-
Low, K.B.1
Ittensohn, M.2
Le, T.3
Platt, J.4
Sodi, S.5
Amoss, M.6
Ash, O.7
Carmichael, E.8
Chakraborty, A.9
Fischer, J.10
Lin, S.L.11
Luo, X.12
Miller, S.I.13
Zheng, L.M.14
King, I.15
Pawelek, J.M.16
Bermudes, D.17
-
24
-
-
34547542844
-
Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein
-
[24] Foligne, B., Dessein, R., Marceau, M., Poiret, S., Chamaillard, M., Pot, B., Simonet, M., Daniel, C., Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein. Gastroenterology 133 (2007), 862–874.
-
(2007)
Gastroenterology
, vol.133
, pp. 862-874
-
-
Foligne, B.1
Dessein, R.2
Marceau, M.3
Poiret, S.4
Chamaillard, M.5
Pot, B.6
Simonet, M.7
Daniel, C.8
-
25
-
-
0034714188
-
Treatment of murine colitis by Lactococcus lactis secreting interleukin-10
-
[25] Steidler, L., Hans, W., Schotte, L., Neirynck, S., Obermeier, F., Falk, W., Fiers, W., Remaut, E., Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289 (2000), 1352–1355.
-
(2000)
Science
, vol.289
, pp. 1352-1355
-
-
Steidler, L.1
Hans, W.2
Schotte, L.3
Neirynck, S.4
Obermeier, F.5
Falk, W.6
Fiers, W.7
Remaut, E.8
-
26
-
-
84964694501
-
Engineered commensal bacteria reprogram intestinal cells into glucose-responsive insulin-secreting cells for the treatment of diabetes
-
[26] Duan, F.F., Liu, J.H., March, J.C., Engineered commensal bacteria reprogram intestinal cells into glucose-responsive insulin-secreting cells for the treatment of diabetes. Diabetes 64:5 (2015), 1794–1803.
-
(2015)
Diabetes
, vol.64
, Issue.5
, pp. 1794-1803
-
-
Duan, F.F.1
Liu, J.H.2
March, J.C.3
-
27
-
-
0035909908
-
Combination bacteriolytic therapy for the treatment of experimental tumors
-
[27] Dang, L.H., Bettegowda, C., Huso, D.L., Kinzler, K.W., Vogelstein, B., Combination bacteriolytic therapy for the treatment of experimental tumors. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 15155–15160.
-
(2001)
Proc. Natl. Acad. Sci. U. S. A.
, vol.98
, pp. 15155-15160
-
-
Dang, L.H.1
Bettegowda, C.2
Huso, D.L.3
Kinzler, K.W.4
Vogelstein, B.5
-
28
-
-
33749532310
-
Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N
-
[28] Liu, X., Lagenaur, L.A., Simpson, D.A., Essenmacher, K.P., Frazier-Parker, C.L., Liu, Y., Tsai, D., Rao, S.S., Hamer, D.H., Parks, T.P., Lee, P.P., Xu, Q., Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N. Antimicrob. Agents Chemother. 50 (2006), 3250–3259.
-
(2006)
Antimicrob. Agents Chemother.
, vol.50
, pp. 3250-3259
-
-
Liu, X.1
Lagenaur, L.A.2
Simpson, D.A.3
Essenmacher, K.P.4
Frazier-Parker, C.L.5
Liu, Y.6
Tsai, D.7
Rao, S.S.8
Hamer, D.H.9
Parks, T.P.10
Lee, P.P.11
Xu, Q.12
-
29
-
-
84982798962
-
Synthetic biology: bacteria synchronized for drug delivery
-
[29] Zhou, S., Synthetic biology: bacteria synchronized for drug delivery. Nature 536 (2016), 33–34.
-
(2016)
Nature
, vol.536
, pp. 33-34
-
-
Zhou, S.1
-
30
-
-
84982836605
-
Synchronized cycles of bacterial lysis for in vivo delivery
-
[30] Din, M.O., Danino, T., Prindle, A., Skalak, M., Selimkhanov, J., Allen, K., Julio, E., Atolia, E., Tsimring, L.S., Bhatia, S.N., Hasty, J., Synchronized cycles of bacterial lysis for in vivo delivery. Nature 536 (2016), 81–85.
-
(2016)
Nature
, vol.536
, pp. 81-85
-
-
Din, M.O.1
Danino, T.2
Prindle, A.3
Skalak, M.4
Selimkhanov, J.5
Allen, K.6
Julio, E.7
Atolia, E.8
Tsimring, L.S.9
Bhatia, S.N.10
Hasty, J.11
-
31
-
-
77958488277
-
Engineering the perfect (bacterial) cancer therapy
-
[31] Forbes, N.S., Engineering the perfect (bacterial) cancer therapy. Nat. Rev. Cancer 10 (2010), 785–794.
-
(2010)
Nat. Rev. Cancer
, vol.10
, pp. 785-794
-
-
Forbes, N.S.1
-
32
-
-
84906716856
-
Magnetic steering control of multi-cellular bio-hybrid microswimmers
-
[32] Carlsen, R.W., Edwards, M.R., Zhuang, J., Pacoret, C., Sitti, M., Magnetic steering control of multi-cellular bio-hybrid microswimmers. Lab Chip 14 (2014), 3850–3859.
-
(2014)
Lab Chip
, vol.14
, pp. 3850-3859
-
-
Carlsen, R.W.1
Edwards, M.R.2
Zhuang, J.3
Pacoret, C.4
Sitti, M.5
-
33
-
-
84908479106
-
Bio-hybrid cell-based actuators for microsystems
-
[33] Carlsen, R.W., Sitti, M., Bio-hybrid cell-based actuators for microsystems. Small 10 (2014), 3831–3851.
-
(2014)
Small
, vol.10
, pp. 3831-3851
-
-
Carlsen, R.W.1
Sitti, M.2
-
34
-
-
84928112296
-
Synthetic microbes as drug delivery systems
-
[34] Claesen, J., Fischbach, M.A., Synthetic microbes as drug delivery systems. ACS Synth. Biol. 4 (2015), 358–364.
-
(2015)
ACS Synth. Biol.
, vol.4
, pp. 358-364
-
-
Claesen, J.1
Fischbach, M.A.2
-
35
-
-
33744933432
-
A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease
-
[35] Braat, H., Rottiers, P., Hommes, D.W., Huyghebaert, N., Remaut, E., Remon, J.P., van Deventer, S.J.H., Neirynck, S., Peppelenbosch, M.P., Steidler, L., A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin. Gastroenterol. Hepatol. 4 (2006), 754–759.
-
(2006)
Clin. Gastroenterol. Hepatol.
, vol.4
, pp. 754-759
-
-
Braat, H.1
Rottiers, P.2
Hommes, D.W.3
Huyghebaert, N.4
Remaut, E.5
Remon, J.P.6
van Deventer, S.J.H.7
Neirynck, S.8
Peppelenbosch, M.P.9
Steidler, L.10
-
36
-
-
84994901830
-
-
A. N.V., Study to Assess Safety and Tolerability of AG013 in Oral Mucositis in Subjects Receiving Induction Chemotherapy for the Treatment of Cancers of the Head and Neck, in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (Jan 2014-May 2016, available from: NLM Identifier: NCT00938080).
-
[36] A. N.V., Study to Assess Safety and Tolerability of AG013 in Oral Mucositis in Subjects Receiving Induction Chemotherapy for the Treatment of Cancers of the Head and Neck, in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (Jan 2014-May 2016, available from: https://clinicaltrials.gov/ct2/show/NCT00938080?term=bacteria&cond=cancer&intr=biological&rank=2, NLM Identifier: NCT00938080).
-
-
-
-
37
-
-
84994828649
-
-
N.C.I. (NCI), Treatment of patients with cancer with genetically modified Salmonella typhimurium bacteria, in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (March 2008-May 2016, available from: NLM Identifier: NCT00004988).
-
[37] N.C.I. (NCI), Treatment of patients with cancer with genetically modified Salmonella typhimurium bacteria, in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (March 2008-May 2016, available from: https://clinicaltrials.gov/ct2/show/NCT00004988, NLM Identifier: NCT00004988).
-
-
-
-
38
-
-
84994903244
-
VNP20009 in treating patients with advanced solid tumors
-
ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (Jul 2013-May 2016, available from: NLM Identifier: NCT00006254).
-
[38] V. Pharmaceuticals, VNP20009 in treating patients with advanced solid tumors, in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (Jul 2013-May 2016, available from: https://clinicaltrials.gov/ct2/show/NCT00006254?term=VNP20009&rank=1, NLM Identifier: NCT00006254).
-
-
-
Pharmaceuticals, V.1
-
39
-
-
84994903244
-
VNP20009 in treating patients with advanced or metastatic solid tumors that have not responded to previous therapy
-
ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (Jul 2013-available from: NLM Identifier: NCT00004216).
-
[39] V. Pharmaceuticals, VNP20009 in treating patients with advanced or metastatic solid tumors that have not responded to previous therapy, in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (Jul 2013-available from: https://clinicaltrials.gov/ct2/show/NCT00004216?term=VNP20009&rank=2, NLM Identifier: NCT00004216).
-
-
-
Pharmaceuticals, V.1
-
40
-
-
84994859271
-
-
U.o.M. Masonic Cancer Center, IL-2 expressing, attenuated Salmonella typhimurium in unresectable hepatic spread, in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (Jan 2016-May 2016, available from: NLM Identifier: NCT01099631).
-
[40] U.o.M. Masonic Cancer Center, IL-2 expressing, attenuated Salmonella typhimurium in unresectable hepatic spread, in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (Jan 2016-May 2016, available from: https://clinicaltrials.gov/ct2/show/NCT01099631?term=salmonella&rank=1, NLM Identifier: NCT01099631).
-
-
-
-
41
-
-
84994877674
-
-
Valley Discoveries, Safety study of intratumoral injection of Clostridium novyi-NT spores to treat patients with solid tumors that have not responded to standard therapies, in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (March 2016-May 2016, available from: NLM Identifier: NCT01924689)
-
[41] I. BioMed Valley Discoveries, Safety study of intratumoral injection of Clostridium novyi-NT spores to treat patients with solid tumors that have not responded to standard therapies, in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (March 2016-May 2016, available from: https://clinicaltrials.gov/ct2/show/NCT01924689?term=C.+novyi-NT&rank=3 NLM Identifier: NCT01924689).
-
-
-
BioMed, I.1
-
42
-
-
84954364589
-
A phase I/II evaluation of ADXS11-001, mitomycin, 5-fluorouracil (5-FU) and IMRT for anal cancer (276)
-
ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (May 2016-May 2016, available from: NLM Identifier: NCT01671488).
-
[42] B. University, A phase I/II evaluation of ADXS11-001, mitomycin, 5-fluorouracil (5-FU) and IMRT for anal cancer (276), in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (May 2016-May 2016, available from: https://clinicaltrials.gov/ct2/show/NCT01671488?term=ADXS11-001&rank=1, NLM Identifier: NCT01671488).
-
-
-
University, B.1
-
43
-
-
84961157835
-
Vaccine therapy in treating patients with persistent or recurrent cervical cancer
-
ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (May 2016-May 2016, available from: NLM Identifier: NCT01266460).
-
[43] G.O. Group, Vaccine therapy in treating patients with persistent or recurrent cervical cancer, in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (May 2016-May 2016, available from: https://clinicaltrials.gov/ct2/show/NCT01266460?term=cervix+listeria&rank=1, NLM Identifier: NCT01266460).
-
-
-
Group, G.O.1
-
44
-
-
85044559640
-
A study of pemetrexed maintenance with or without ADXS11-001 immunotherapy in patients with human papillomavirus positive (HPV +), NSCLC following first-line induction chemotherapy
-
= ADXS11-001&rank = 7, NLM Identifier: NCT02531854., Dec 2015–May 2016, available from:
-
[44] I. Advaxis, A study of pemetrexed maintenance with or without ADXS11-001 immunotherapy in patients with human papillomavirus positive (HPV +), NSCLC following first-line induction chemotherapy, in: Dec 2015–May 2016, available from: https://clinicaltrials.gov/ct2/show/NCT02531854?term = ADXS11-001&rank = 7, NLM Identifier: NCT02531854.
-
-
-
Advaxis, I.1
-
45
-
-
85044560607
-
Phase 2 Study of ADXS11-001 in subjects with anal cancer or cancer of the rectum
-
= ADXS11-001&rank = 6, NLM Identifier: NCT02399813., Dec 2015-May 2016, available from:
-
[45] I. Advaxis, Phase 2 Study of ADXS11-001 in subjects with anal cancer or cancer of the rectum, in: Dec 2015-May 2016, available from: https://clinicaltrials.gov/ct2/show/NCT02399813?term = ADXS11-001&rank = 6, NLM Identifier: NCT02399813.
-
-
-
Advaxis, I.1
-
46
-
-
85044555945
-
-
= ADXS11-001&rank = 5, NLM Identifier: NCT02291055., Phase 1–2 study of ADXS11-001 or MEDI4736 alone or combo in cervical or HPV + head & neck cancer, in: May 2016–May 2016, available from:
-
[46] I. Advaxis, Phase 1–2 study of ADXS11-001 or MEDI4736 alone or combo in cervical or HPV + head & neck cancer, in: May 2016–May 2016, available from: https://clinicaltrials.gov/ct2/show/NCT02291055?term = ADXS11-001&rank = 5, NLM Identifier: NCT02291055.
-
-
-
Advaxis, I.1
-
47
-
-
84961155580
-
ADXS11-001 high dose HPV + cervical cancer
-
= ADXS11-001&rank = 3, NLM Identifier: NCT02164461)., ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (Apr 2016-May 2016, available from:
-
[47] I. Advaxis, ADXS11-001 high dose HPV + cervical cancer, in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (Apr 2016-May 2016, available from: https://clinicaltrials.gov/ct2/show/NCT02164461?term = ADXS11-001&rank = 3, NLM Identifier: NCT02164461).
-
-
-
Advaxis, I.1
-
48
-
-
85044552899
-
ADXS 11-001 vaccination prior to robotic surgery, HPV-positive oropharyngeal cancer
-
= ADXS11-001&rank = 2, NLM Identifier: NCT02002182)., ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (Apr 2016–May 2016, available from:
-
[48] A. Sikora, ADXS 11-001 vaccination prior to robotic surgery, HPV-positive oropharyngeal cancer, in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (Apr 2016–May 2016, available from: https://clinicaltrials.gov/ct2/show/NCT02002182?term = ADXS11-001&rank = 2, NLM Identifier: NCT02002182).
-
-
-
Sikora, A.1
-
49
-
-
85044556585
-
-
= Genetically + Modified + Bacteria&rank = 4, NLM Identifier: NCT01598792., U.o. Liverpool, Safety study of recombinant Listeria monocytogenes-based vaccine virus vaccine to treat oropharyngeal cancer (realistic:), in: May 2016–May 2016, available from:
-
[49] U.o. Liverpool, Safety study of recombinant Listeria monocytogenes-based vaccine virus vaccine to treat oropharyngeal cancer (realistic:), in: May 2016–May 2016, available from: https://clinicaltrials.gov/ct2/show/NCT01598792?term = Genetically + Modified + Bacteria&rank = 4, NLM Identifier: NCT01598792.
-
-
-
-
50
-
-
84994887462
-
-
= bacteria&cond = cancer&intr = biological&rank = 15, NLM Identifier: NCT02592967)., Research & Development, Safety & immunogenicity Of JNJ-64041757, live-attenuated double-deleted listeria immunotherapy, in subjects with non-small cell lung cancer, in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (Apr 2016-May 2016, available from:
-
[50] L. Janssen Research & Development, Safety & immunogenicity Of JNJ-64041757, live-attenuated double-deleted listeria immunotherapy, in subjects with non-small cell lung cancer, in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (Apr 2016-May 2016, available from: https://clinicaltrials.gov/ct2/show/NCT02592967?term = bacteria&cond = cancer&intr = biological&rank = 15, NLM Identifier: NCT02592967).
-
-
-
Janssen, L.1
-
51
-
-
84994868141
-
-
= bacteria&cond = cancer&intr = biological&rank = 7, NLM Identifier: NCT02625857)., Research & Development, Safety & immunogenicity of JNJ-64041809, a live attenuated double-deleted listeria immunotherapy, in participants with metastatic castration-resistant prostate cancer, in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (Dec 2015-available from:
-
[51] L. Janssen Research & Development, Safety & immunogenicity of JNJ-64041809, a live attenuated double-deleted listeria immunotherapy, in participants with metastatic castration-resistant prostate cancer, in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (Dec 2015-available from: https://clinicaltrials.gov/ct2/show/NCT02625857?term = bacteria&cond = cancer&intr = biological&rank = 7, NLM Identifier: NCT02625857).
-
-
-
Janssen, L.1
-
52
-
-
84994845736
-
-
= Genetically + Modified + Bacteria&rank = 5, NLM Identifier: NCT00585845)., Therapeutics, Study of safety and tolerability of intravenous CRS-207 in adults with selected advanced solid tumors who have failed or who are not candidates for standard treatment, in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (Feb 2009-May 2016, available from:
-
[52] I. Anza Therapeutics, Study of safety and tolerability of intravenous CRS-207 in adults with selected advanced solid tumors who have failed or who are not candidates for standard treatment, in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (Feb 2009-May 2016, available from: https://clinicaltrials.gov/ct2/show/NCT00585845?term = Genetically + Modified + Bacteria&rank = 5, NLM Identifier: NCT00585845).
-
-
-
Anza, I.1
-
53
-
-
85044547309
-
-
= CRS-207&rank = 5, NLM Identifier: NCT01675765)., Biotech, Safety and efficacy of Listeria in combination with chemotherapy as front-line treatment for malignant pleural mesothelioma, in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (Aug 2015-May 2016, available from:
-
[53] I. Aduro Biotech, Safety and efficacy of Listeria in combination with chemotherapy as front-line treatment for malignant pleural mesothelioma, in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (Aug 2015-May 2016, available from: https://clinicaltrials.gov/ct2/show/NCT01675765?term = CRS-207&rank = 5, NLM Identifier: NCT01675765).
-
-
-
Aduro, I.1
-
54
-
-
84978879227
-
GVAX pancreas vaccine (with CY) and CRS-207 with or without Nivolumab
-
= CRS-207&rank = 1, NLM Identifier: NCT02243371)., ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (MAr 2016-May 2016, available from:
-
[54] S.K.C.C. Center, GVAX pancreas vaccine (with CY) and CRS-207 with or without Nivolumab, in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (MAr 2016-May 2016, available from: https://clinicaltrials.gov/ct2/show/NCT02243371?term = CRS-207&rank = 1, NLM Identifier: NCT02243371).
-
-
-
Center, S.K.C.C.1
-
55
-
-
85044553686
-
-
= CRS-207&rank = 2, NLM Identifier: NCT02575807)., Biotech, Safety and efficacy of CRS-207 with epacadostat in platinum resistant ovarian, fallopian, or peritoneal cancer (SEASCAPE), in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (May 2016-May 2016, available from:
-
[55] I. Aduro Biotech, Safety and efficacy of CRS-207 with epacadostat in platinum resistant ovarian, fallopian, or peritoneal cancer (SEASCAPE), in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (May 2016-May 2016, available from: https://clinicaltrials.gov/ct2/show/NCT02575807?term = CRS-207&rank = 2, NLM Identifier: NCT02575807).
-
-
-
Aduro, I.1
-
56
-
-
85044559463
-
-
= CRS-207&rank = 4, NLM Identifier: NCT01417000)., Biotech, Safety and efficacy of combination Listeria/GVAX immunotherapy in pancreatic cancer, in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (Jan 2016-May 2016, available from:
-
[56] I. Aduro Biotech, Safety and efficacy of combination Listeria/GVAX immunotherapy in pancreatic cancer, in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (Jan 2016-May 2016, available from: https://clinicaltrials.gov/ct2/show/NCT01417000?term = CRS-207&rank = 4, NLM Identifier: NCT01417000).
-
-
-
Aduro, I.1
-
57
-
-
85044559057
-
-
= CRS-207&rank = 6, NLM Identifier: NCT02004262)., Biotech, Safety and efficacy of combination Listeria/GVAX pancreas vaccine in the pancreatic cancer setting (ECLIPSE), in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (Aug 2015-available from:
-
[57] I. Aduro Biotech, Safety and efficacy of combination Listeria/GVAX pancreas vaccine in the pancreatic cancer setting (ECLIPSE), in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (Aug 2015-available from: https://clinicaltrials.gov/ct2/show/NCT02004262?term = CRS-207&rank = 6, NLM Identifier: NCT02004262).
-
-
-
Aduro, I.1
-
58
-
-
85044549939
-
A phase 1/2 study of HS-410 in patients with non-muscle invasive bladder cancer after TURBT
-
= bacteria&cond = cancer&intr = biological&rank = 3, NLM Identifier: NCT02010203)., ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (Mar 2016-May 2016, available from:
-
[58] H. Biologics, A phase 1/2 study of HS-410 in patients with non-muscle invasive bladder cancer after TURBT, in: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), (Mar 2016-May 2016, available from: https://clinicaltrials.gov/ct2/show/NCT02010203?term = bacteria&cond = cancer&intr = biological&rank = 3, NLM Identifier: NCT02010203).
-
-
-
Biologics, H.1
-
59
-
-
27144534030
-
Direct observation of steps in rotation of the bacterial flagellar motor
-
[59] Sowa, Y., Rowe, A.D., Leake, M.C., Yakushi, T., Homma, M., Ishijima, A., Berry, R.M., Direct observation of steps in rotation of the bacterial flagellar motor. Nature 437 (2005), 916–919.
-
(2005)
Nature
, vol.437
, pp. 916-919
-
-
Sowa, Y.1
Rowe, A.D.2
Leake, M.C.3
Yakushi, T.4
Homma, M.5
Ishijima, A.6
Berry, R.M.7
-
60
-
-
84877045406
-
Bacterial microsystems and microrobots
-
[60] Martel, S., Bacterial microsystems and microrobots. Biomed. Microdevices 14 (2012), 1033–1045.
-
(2012)
Biomed. Microdevices
, vol.14
, pp. 1033-1045
-
-
Martel, S.1
-
61
-
-
77955652704
-
A field guide to bacterial swarming motility
-
[61] Kearns, D.B., A field guide to bacterial swarming motility. Nat. Rev. Microbiol. 8 (2010), 634–644.
-
(2010)
Nat. Rev. Microbiol.
, vol.8
, pp. 634-644
-
-
Kearns, D.B.1
-
62
-
-
44949129715
-
Evolution of taxis responses in virtual bacteria: non-adaptive dynamics
-
[62] Goldstein, R.A., Soyer, O.S., Evolution of taxis responses in virtual bacteria: non-adaptive dynamics. PLoS Comput. Biol., 4, 2008, e1000084.
-
(2008)
PLoS Comput. Biol.
, vol.4
, pp. e1000084
-
-
Goldstein, R.A.1
Soyer, O.S.2
-
63
-
-
0032694979
-
Aerotaxis and other energy-sensing behavior in bacteria
-
[63] Taylor, B.L., Zhulin, I.B., Johnson, M.S., Aerotaxis and other energy-sensing behavior in bacteria. Annu. Rev. Microbiol. 53 (1999), 103–128.
-
(1999)
Annu. Rev. Microbiol.
, vol.53
, pp. 103-128
-
-
Taylor, B.L.1
Zhulin, I.B.2
Johnson, M.S.3
-
64
-
-
84957608208
-
Tumor-targeting therapy using gene-engineered anaerobic-nonpathogenic Bifidobacterium longum
-
[64] Taniguchi, S., Shimatani, Y., Fujimori, M., Tumor-targeting therapy using gene-engineered anaerobic-nonpathogenic Bifidobacterium longum. Methods Mol. Biol. 1409 (2016), 49–60.
-
(2016)
Methods Mol. Biol.
, vol.1409
, pp. 49-60
-
-
Taniguchi, S.1
Shimatani, Y.2
Fujimori, M.3
-
65
-
-
84871012696
-
Opposite responses by different chemoreceptors set a tunable preference point in Escherichia coli pH taxis
-
[65] Yang, Y., Sourjik, V., Opposite responses by different chemoreceptors set a tunable preference point in Escherichia coli pH taxis. Mol. Microbiol. 86 (2012), 1482–1489.
-
(2012)
Mol. Microbiol.
, vol.86
, pp. 1482-1489
-
-
Yang, Y.1
Sourjik, V.2
-
66
-
-
84988914055
-
Engineered bacteria detect spatial profiles in glucose concentration within solid tumor cell masses
-
[66] Panteli, J.T., Forbes, N.S., Engineered bacteria detect spatial profiles in glucose concentration within solid tumor cell masses. Biotechnol. Bioeng., 2016, 10.1002/bit.26006.
-
(2016)
Biotechnol. Bioeng.
-
-
Panteli, J.T.1
Forbes, N.S.2
-
67
-
-
61349153696
-
A novel human Her-2/neu chimeric molecule expressed by Listeria monocytogenes can elicit potent HLA-A2 restricted CD8-positive T cell responses and impact the growth and spread of Her-2/neu-positive breast tumors
-
[67] Seavey, M.M., Pan, Z.K., Maciag, P.C., Wallecha, A., Rivera, S., Paterson, Y., Shahabi, V., A novel human Her-2/neu chimeric molecule expressed by Listeria monocytogenes can elicit potent HLA-A2 restricted CD8-positive T cell responses and impact the growth and spread of Her-2/neu-positive breast tumors. Clin. Cancer Res. 15 (2009), 924–932.
-
(2009)
Clin. Cancer Res.
, vol.15
, pp. 924-932
-
-
Seavey, M.M.1
Pan, Z.K.2
Maciag, P.C.3
Wallecha, A.4
Rivera, S.5
Paterson, Y.6
Shahabi, V.7
-
68
-
-
33750480202
-
Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo
-
[68] Theys, J., Pennington, O., Dubois, L., Anlezark, G., Vaughan, T., Mengesha, A., Landuyt, W., Anne, J., Burke, P.J., Durre, P., Wouters, B.G., Minton, N.P., Lambin, P., Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo. Br. J. Cancer 95 (2006), 1212–1219.
-
(2006)
Br. J. Cancer
, vol.95
, pp. 1212-1219
-
-
Theys, J.1
Pennington, O.2
Dubois, L.3
Anlezark, G.4
Vaughan, T.5
Mengesha, A.6
Landuyt, W.7
Anne, J.8
Burke, P.J.9
Durre, P.10
Wouters, B.G.11
Minton, N.P.12
Lambin, P.13
-
69
-
-
84945917715
-
A novel lumazine synthase molecule from Brucella significantly promotes the immune-stimulation effects of antigenic protein
-
[69] Du, Z.Q., Wang, J.Y., A novel lumazine synthase molecule from Brucella significantly promotes the immune-stimulation effects of antigenic protein. Genet. Mol. Res. 14 (2015), 13084–13095.
-
(2015)
Genet. Mol. Res.
, vol.14
, pp. 13084-13095
-
-
Du, Z.Q.1
Wang, J.Y.2
-
70
-
-
84949870540
-
Activation of multiple chemotherapeutic prodrugs by the natural enzymolome of tumour-localised probiotic bacteria
-
[70] Lehouritis, P., Stanton, M., McCarthy, F.O., Jeavons, M., Tangney, M., Activation of multiple chemotherapeutic prodrugs by the natural enzymolome of tumour-localised probiotic bacteria. J. Control. Release 222 (2016), 9–17.
-
(2016)
J. Control. Release
, vol.222
, pp. 9-17
-
-
Lehouritis, P.1
Stanton, M.2
McCarthy, F.O.3
Jeavons, M.4
Tangney, M.5
-
71
-
-
0021354414
-
A colon-specific drug-delivery system based on drug glycosides and the glycosidases of colonic bacteria
-
[71] Friend, D.R., Chang, G.W., A colon-specific drug-delivery system based on drug glycosides and the glycosidases of colonic bacteria. J. Med. Chem. 27 (1984), 261–266.
-
(1984)
J. Med. Chem.
, vol.27
, pp. 261-266
-
-
Friend, D.R.1
Chang, G.W.2
-
72
-
-
0025050623
-
Microbially controlled drug delivery to the colon
-
[72] Rubinstein, A., Microbially controlled drug delivery to the colon. Biopharm. Drug Dispos. 11 (1990), 465–475.
-
(1990)
Biopharm. Drug Dispos.
, vol.11
, pp. 465-475
-
-
Rubinstein, A.1
-
73
-
-
84858760109
-
Combining immunotherapy and targeted therapies in cancer treatment
-
[73] Vanneman, M., Dranoff, G., Combining immunotherapy and targeted therapies in cancer treatment. Nat. Rev. Cancer 12 (2012), 237–251.
-
(2012)
Nat. Rev. Cancer
, vol.12
, pp. 237-251
-
-
Vanneman, M.1
Dranoff, G.2
-
74
-
-
57149083657
-
Potent anti-tumor activity of systemically-administered IL2-expressing Salmonella correlates with decreased angiogenesis and enhanced tumor apoptosis
-
[74] al-Ramadi, B.K., Fernandez-Cabezudo, M.J., El-Hasasna, H., Al-Salam, S., Bashir, G., Chouaib, S., Potent anti-tumor activity of systemically-administered IL2-expressing Salmonella correlates with decreased angiogenesis and enhanced tumor apoptosis. Clin. Immunol. 130 (2009), 89–97.
-
(2009)
Clin. Immunol.
, vol.130
, pp. 89-97
-
-
al-Ramadi, B.K.1
Fernandez-Cabezudo, M.J.2
El-Hasasna, H.3
Al-Salam, S.4
Bashir, G.5
Chouaib, S.6
-
75
-
-
18144385828
-
Secretory production of biologically active rat interleukin-2 by Clostridium acetobutylicum DSM792 as a tool for anti-tumor treatment
-
[75] Barbe, S., Van Mellaert, L., Theys, J., Geukens, N., Lammertyn, E., Lambin, P., Anne, J., Secretory production of biologically active rat interleukin-2 by Clostridium acetobutylicum DSM792 as a tool for anti-tumor treatment. FEMS Microbiol. Lett. 246 (2005), 67–73.
-
(2005)
FEMS Microbiol. Lett.
, vol.246
, pp. 67-73
-
-
Barbe, S.1
Van Mellaert, L.2
Theys, J.3
Geukens, N.4
Lammertyn, E.5
Lambin, P.6
Anne, J.7
-
76
-
-
20544437792
-
Attenuated Salmonella typhimurium invades and decreases tumor burden in neuroblastoma
-
[76] Barnett, S.J., Soto Iii, L.J., Sorenson, B.S., Nelson, B.W., Leonard, A.S., Saltzman, D.A., Attenuated Salmonella typhimurium invades and decreases tumor burden in neuroblastoma. J. Pediatr. Surg. 40 (2005), 993–998.
-
(2005)
J. Pediatr. Surg.
, vol.40
, pp. 993-998
-
-
Barnett, S.J.1
Soto Iii, L.J.2
Sorenson, B.S.3
Nelson, B.W.4
Leonard, A.S.5
Saltzman, D.A.6
-
77
-
-
0036403302
-
Liver and circulating NK1.1 + CD3- cells are increased in infection with attenuated Salmonella typhimurium and are associated with reduced tumor in murine liver cancer
-
[77] Feltis, B.A., Miller, J.S., Sahar, D.A., Kim, A.S., Saltzman, D.A., Leonard, A.S., Wells, C.L., Sielaff, T.D., Liver and circulating NK1.1 + CD3- cells are increased in infection with attenuated Salmonella typhimurium and are associated with reduced tumor in murine liver cancer. J. Surg. Res. 107 (2002), 101–107.
-
(2002)
J. Surg. Res.
, vol.107
, pp. 101-107
-
-
Feltis, B.A.1
Miller, J.S.2
Sahar, D.A.3
Kim, A.S.4
Saltzman, D.A.5
Leonard, A.S.6
Wells, C.L.7
Sielaff, T.D.8
-
78
-
-
0029936191
-
Attenuated Salmonella typhimurium containing interleukin-2 decreases MC-38 hepatic metastases: a novel anti-tumor agent
-
[78] Saltzman, D.A., Heise, C.P., Hasz, D.E., Zebede, M., Kelly, S.M., Curtiss Iii, R., Leonard, A.S., Anderson, P.M., Attenuated Salmonella typhimurium containing interleukin-2 decreases MC-38 hepatic metastases: a novel anti-tumor agent. Cancer Biother. Radiopharm. 11 (1996), 145–153.
-
(1996)
Cancer Biother. Radiopharm.
, vol.11
, pp. 145-153
-
-
Saltzman, D.A.1
Heise, C.P.2
Hasz, D.E.3
Zebede, M.4
Kelly, S.M.5
Curtiss Iii, R.6
Leonard, A.S.7
Anderson, P.M.8
-
79
-
-
0031044363
-
Antitumor mechanisms of attenuated Salmonella typhimurium containing the gene for human interleukin-2: a novel antitumor agent?
-
[79] Saltzman, D.A., Katsanis, E., Heise, C.P., Hasz, D.E., Vigdorovich, V., Kelly, S.M., Curtiss Iii, R., Leonard, A.S., Anderson, P.M., Antitumor mechanisms of attenuated Salmonella typhimurium containing the gene for human interleukin-2: a novel antitumor agent?. J. Pediatr. Surg. 32 (1997), 301–306.
-
(1997)
J. Pediatr. Surg.
, vol.32
, pp. 301-306
-
-
Saltzman, D.A.1
Katsanis, E.2
Heise, C.P.3
Hasz, D.E.4
Vigdorovich, V.5
Kelly, S.M.6
Curtiss Iii, R.7
Leonard, A.S.8
Anderson, P.M.9
-
80
-
-
44949134116
-
Attenuated Salmonella typhimurium with interleukin 2 gene prevents the establishment of pulmonary metastases in a model of osteosarcoma
-
[80] Sorenson, B.S., Banton, K.L., Frykman, N.L., Leonard, A.S., Saltzman, D.A., Attenuated Salmonella typhimurium with interleukin 2 gene prevents the establishment of pulmonary metastases in a model of osteosarcoma. J. Pediatr. Surg. 43 (2008), 1153–1158.
-
(2008)
J. Pediatr. Surg.
, vol.43
, pp. 1153-1158
-
-
Sorenson, B.S.1
Banton, K.L.2
Frykman, N.L.3
Leonard, A.S.4
Saltzman, D.A.5
-
81
-
-
84899679316
-
Recombinant protein expression in Escherichia coli: advances and challenges
-
[81] Rosano, G.L., Ceccarelli, E.A., Recombinant protein expression in Escherichia coli: advances and challenges. Front. Microbiol., 5, 2014, 172.
-
(2014)
Front. Microbiol.
, vol.5
, pp. 172
-
-
Rosano, G.L.1
Ceccarelli, E.A.2
-
82
-
-
0019195025
-
Direct transfer of cloned genes from bacteria to mammalian-cells
-
[82] Schaffner, W., Direct transfer of cloned genes from bacteria to mammalian-cells. Proc. Natl. Acad. Sci. U. S. A. Biol. Sci. 77 (1980), 2163–2167.
-
(1980)
Proc. Natl. Acad. Sci. U. S. A. Biol. Sci.
, vol.77
, pp. 2163-2167
-
-
Schaffner, W.1
-
83
-
-
29944435270
-
Bacteria in gene therapy: bactofection versus alternative gene therapy
-
[83] Palffy, R., Gardlik, R., Hodosy, J., Behuliak, M., Resko, P., Radvansky, J., Celec, P., Bacteria in gene therapy: bactofection versus alternative gene therapy. Gene Ther. 13 (2006), 101–105.
-
(2006)
Gene Ther.
, vol.13
, pp. 101-105
-
-
Palffy, R.1
Gardlik, R.2
Hodosy, J.3
Behuliak, M.4
Resko, P.5
Radvansky, J.6
Celec, P.7
-
84
-
-
84864296504
-
New perspectives into bacterial DNA transfer to human cells
-
[84] Llosa, M., Schroder, G., Dehio, C., New perspectives into bacterial DNA transfer to human cells. Trends Microbiol. 20 (2012), 355–359.
-
(2012)
Trends Microbiol.
, vol.20
, pp. 355-359
-
-
Llosa, M.1
Schroder, G.2
Dehio, C.3
-
85
-
-
33749103965
-
Bifidobacterium longum as a delivery system for gene therapy of chemically induced rat mammary tumors
-
[85] Yazawa, K., Fujimori, M., Nakamura, T., Sasaki, T., Amano, J., Kano, Y., Taniguchi, S., Bifidobacterium longum as a delivery system for gene therapy of chemically induced rat mammary tumors. Breast Cancer Res. Treat. 66 (2001), 165–170.
-
(2001)
Breast Cancer Res. Treat.
, vol.66
, pp. 165-170
-
-
Yazawa, K.1
Fujimori, M.2
Nakamura, T.3
Sasaki, T.4
Amano, J.5
Kano, Y.6
Taniguchi, S.7
-
86
-
-
13444257501
-
Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer
-
[86] Fu, G.F., Li, X., Hou, Y.Y., Fan, Y.R., Liu, W.H., Xu, G.X., Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer. Cancer Gene Ther. 12 (2005), 133–140.
-
(2005)
Cancer Gene Ther.
, vol.12
, pp. 133-140
-
-
Fu, G.F.1
Li, X.2
Hou, Y.Y.3
Fan, Y.R.4
Liu, W.H.5
Xu, G.X.6
-
87
-
-
35948942711
-
Effect of interfacial interaction on the cross-sectional morphology of tobacco mosaic virus using GISAXS
-
[87] Lee, B., Lo, C.-T., Thiyagarajan, P., Winans, R.E., Li, X., Niu, Z., Wang, Q., Effect of interfacial interaction on the cross-sectional morphology of tobacco mosaic virus using GISAXS. Langmuir 23 (2007), 11157–11163.
-
(2007)
Langmuir
, vol.23
, pp. 11157-11163
-
-
Lee, B.1
Lo, C.-T.2
Thiyagarajan, P.3
Winans, R.E.4
Li, X.5
Niu, Z.6
Wang, Q.7
-
88
-
-
84922057919
-
The antitumor effect of suicide gene therapy using Bifidobacterium infantise-mediated herpes simplex virus thymidine kinase/ganciclovir in a nude mice model of renal cell carcinoma
-
[88] Xiao, X., Jin, R., Li, J., Bei, Y., Wei, T., The antitumor effect of suicide gene therapy using Bifidobacterium infantise-mediated herpes simplex virus thymidine kinase/ganciclovir in a nude mice model of renal cell carcinoma. Urology, 84, 2014.
-
(2014)
Urology
, vol.84
-
-
Xiao, X.1
Jin, R.2
Li, J.3
Bei, Y.4
Wei, T.5
-
89
-
-
84888111029
-
Proteomic analysis of bladder cancer by iTRAQ after Bifidobacterium infantis-mediated HSV-TK/GCV suicide gene treatment
-
[89] Jiang, L., Ren, J., Xiao, X., Tang, Y.Y., Weng, H.Q., Yang, Q., Wu, M.J., Tang, W., Proteomic analysis of bladder cancer by iTRAQ after Bifidobacterium infantis-mediated HSV-TK/GCV suicide gene treatment. Biol. Chem. 394 (2013), 1333–1342.
-
(2013)
Biol. Chem.
, vol.394
, pp. 1333-1342
-
-
Jiang, L.1
Ren, J.2
Xiao, X.3
Tang, Y.Y.4
Weng, H.Q.5
Yang, Q.6
Wu, M.J.7
Tang, W.8
-
90
-
-
84874107892
-
Bifidobacterium infantis-mediated HSV-TK/GCV suicide gene therapy induces both extrinsic and intrinsic apoptosis in a rat model of bladder cancer
-
[90] Yin, X., Yu, B., Tang, Z., He, B., Ren, J., Xiao, X., Tang, W., Bifidobacterium infantis-mediated HSV-TK/GCV suicide gene therapy induces both extrinsic and intrinsic apoptosis in a rat model of bladder cancer. Cancer Gene Ther. 20 (2013), 77–81.
-
(2013)
Cancer Gene Ther.
, vol.20
, pp. 77-81
-
-
Yin, X.1
Yu, B.2
Tang, Z.3
He, B.4
Ren, J.5
Xiao, X.6
Tang, W.7
-
91
-
-
18844382645
-
Antitumor effect of cytosine deaminase/5-fluorocytosine suicide gene therapy system mediated by Bifidobacterium infantis on melanoma
-
[91] Yi, C., Huang, Y., Guo, Z.Y., Wang, S.R., Antitumor effect of cytosine deaminase/5-fluorocytosine suicide gene therapy system mediated by Bifidobacterium infantis on melanoma. Acta Pharmacol. Sin. 26 (2005), 629–634.
-
(2005)
Acta Pharmacol. Sin.
, vol.26
, pp. 629-634
-
-
Yi, C.1
Huang, Y.2
Guo, Z.Y.3
Wang, S.R.4
-
92
-
-
20444437484
-
Internalin-expres sing Lactococcus lactis is able to invade small intestine of guinea pigs and deliver DNA into mammalian epithelial cells
-
[92] Guimaraes, V.D., Gabriel, J.E., Lefevre, F., Cabanes, D., Gruss, A., Cossart, P., Azevedo, V., Langella, P., Internalin-expres sing Lactococcus lactis is able to invade small intestine of guinea pigs and deliver DNA into mammalian epithelial cells. Microbes Infect. 7 (2005), 836–844.
-
(2005)
Microbes Infect.
, vol.7
, pp. 836-844
-
-
Guimaraes, V.D.1
Gabriel, J.E.2
Lefevre, F.3
Cabanes, D.4
Gruss, A.5
Cossart, P.6
Azevedo, V.7
Langella, P.8
-
93
-
-
33750992813
-
Use of native lactococci as vehicles for delivery of DNA into mammalian epithelial cells
-
[93] Guimaraes, V.D., Innocentin, S., Lefevre, F., Azevedo, V., Wal, J.M., Langella, P., Chatel, J.M., Use of native lactococci as vehicles for delivery of DNA into mammalian epithelial cells. Appl. Environ. Microbiol. 72 (2006), 7091–7097.
-
(2006)
Appl. Environ. Microbiol.
, vol.72
, pp. 7091-7097
-
-
Guimaraes, V.D.1
Innocentin, S.2
Lefevre, F.3
Azevedo, V.4
Wal, J.M.5
Langella, P.6
Chatel, J.M.7
-
94
-
-
48949102868
-
In vivo transfer of plasmid from food-grade transiting lactococci to murine epithelial cells
-
[94] Chatel, J.M., Pothelune, L., Ah-Leung, S., Corthier, G., Wal, J.M., Langella, P., In vivo transfer of plasmid from food-grade transiting lactococci to murine epithelial cells. Gene Ther. 15 (2008), 1184–1190.
-
(2008)
Gene Ther.
, vol.15
, pp. 1184-1190
-
-
Chatel, J.M.1
Pothelune, L.2
Ah-Leung, S.3
Corthier, G.4
Wal, J.M.5
Langella, P.6
-
95
-
-
84872743322
-
A mutant in the Listeria monocytogenes Fur-regulated virulence locus (frvA) induces cellular immunity and confers protection against listeriosis in mice
-
[95] McLaughlin, H.P., Bahey-El-Din, M., Casey, P.G., Hill, C., Gahan, C.G.M., A mutant in the Listeria monocytogenes Fur-regulated virulence locus (frvA) induces cellular immunity and confers protection against listeriosis in mice. J. Med. Microbiol. 62 (2013), 185–190.
-
(2013)
J. Med. Microbiol.
, vol.62
, pp. 185-190
-
-
McLaughlin, H.P.1
Bahey-El-Din, M.2
Casey, P.G.3
Hill, C.4
Gahan, C.G.M.5
-
96
-
-
78650082236
-
The use of Listeria monocytogenes as a DNA delivery vector for cancer gene therapy
-
[96] Tangney, M., van Pijkeren, J.P., Gahan, C.G.M., The use of Listeria monocytogenes as a DNA delivery vector for cancer gene therapy. Bioengineered Bugs 1 (2010), 284–287.
-
(2010)
Bioengineered Bugs
, vol.1
, pp. 284-287
-
-
Tangney, M.1
van Pijkeren, J.P.2
Gahan, C.G.M.3
-
97
-
-
0031911627
-
Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes
-
[97] Dietrich, G., Bubert, A., Gentschev, I., Sokolovic, Z., Simm, A., Catic, A., Kaufmann, S.H.E., Hess, J., Szalay, A.A., Goebel, W., Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes. Nat. Biotechnol. 16 (1998), 181–185.
-
(1998)
Nat. Biotechnol.
, vol.16
, pp. 181-185
-
-
Dietrich, G.1
Bubert, A.2
Gentschev, I.3
Sokolovic, Z.4
Simm, A.5
Catic, A.6
Kaufmann, S.H.E.7
Hess, J.8
Szalay, A.A.9
Goebel, W.10
-
98
-
-
17844397213
-
Bacterial delivery of functional messenger RNA to mammalian cells
-
[98] Schoen, C., Kolb-Maurer, A., Geginat, G., Loffler, D., Bergmann, B., Stritzker, J., Szalay, A.A., Pilgrim, S., Goebel, W., Bacterial delivery of functional messenger RNA to mammalian cells. Cell. Microbiol. 7 (2005), 709–724.
-
(2005)
Cell. Microbiol.
, vol.7
, pp. 709-724
-
-
Schoen, C.1
Kolb-Maurer, A.2
Geginat, G.3
Loffler, D.4
Bergmann, B.5
Stritzker, J.6
Szalay, A.A.7
Pilgrim, S.8
Goebel, W.9
-
99
-
-
77950795422
-
A novel Listeria monocytogenes-based DNA delivery system for cancer gene therapy
-
[99] van Pijkeren, J.P., Morrissey, D., Monk, I.R., Cronin, M., Rajendran, S., O'Sullivan, G.C., Gahan, C.G.M., Tangney, M., A novel Listeria monocytogenes-based DNA delivery system for cancer gene therapy. Hum. Gene Ther. 21 (2010), 405–416.
-
(2010)
Hum. Gene Ther.
, vol.21
, pp. 405-416
-
-
van Pijkeren, J.P.1
Morrissey, D.2
Monk, I.R.3
Cronin, M.4
Rajendran, S.5
O'Sullivan, G.C.6
Gahan, C.G.M.7
Tangney, M.8
-
100
-
-
0036209879
-
Wild-type intracellular bacteria deliver DNA into mammalian cells
-
[100] Grillot-Courvalin, C., Goussard, S., Courvalin, P., Wild-type intracellular bacteria deliver DNA into mammalian cells. Cell. Microbiol. 4 (2002), 177–186.
-
(2002)
Cell. Microbiol.
, vol.4
, pp. 177-186
-
-
Grillot-Courvalin, C.1
Goussard, S.2
Courvalin, P.3
-
101
-
-
0032860681
-
Bacteria as gene delivery vectors for mammalian cells — commentary
-
[101] Grillot-Courvalin, C., Goussard, S., Courvalin, P., Bacteria as gene delivery vectors for mammalian cells — commentary. Curr. Opin. Biotechnol. 10 (1999), 477–481.
-
(1999)
Curr. Opin. Biotechnol.
, vol.10
, pp. 477-481
-
-
Grillot-Courvalin, C.1
Goussard, S.2
Courvalin, P.3
-
102
-
-
0031721556
-
Functional gene transfer from intracellular bacteria to mammalian cells
-
[102] Grillot-Courvalin, C., Goussard, S., Huetz, F., Ojcius, D.M., Courvalin, P., Functional gene transfer from intracellular bacteria to mammalian cells. Nat. Biotechnol. 16 (1998), 862–866.
-
(1998)
Nat. Biotechnol.
, vol.16
, pp. 862-866
-
-
Grillot-Courvalin, C.1
Goussard, S.2
Huetz, F.3
Ojcius, D.M.4
Courvalin, P.5
-
103
-
-
0029620641
-
Gene transfer from bacteria to mammalian cells
-
[103] Courvalin, P., Goussard, S., GrillotCourvalin, C., Gene transfer from bacteria to mammalian cells. Comptes Rendus De L Academie Des Sciences Serie Iii-Sciences De La Vie-Life Sciences 318 (1995), 1207–1212.
-
(1995)
Comptes Rendus De L Academie Des Sciences Serie Iii-Sciences De La Vie-Life Sciences
, vol.318
, pp. 1207-1212
-
-
Courvalin, P.1
Goussard, S.2
GrillotCourvalin, C.3
-
104
-
-
21744447859
-
Engineered E. coli delivers therapeutic genes to the colonic mucosa
-
[104] Castagliuolo, I., Beggiao, E., Brun, P., Barzon, L., Goussard, S., Manganelli, R., Grillot-Courvalin, C., Palu, G., Engineered E. coli delivers therapeutic genes to the colonic mucosa. Gene Ther. 12 (2005), 1070–1078.
-
(2005)
Gene Ther.
, vol.12
, pp. 1070-1078
-
-
Castagliuolo, I.1
Beggiao, E.2
Brun, P.3
Barzon, L.4
Goussard, S.5
Manganelli, R.6
Grillot-Courvalin, C.7
Palu, G.8
-
105
-
-
1642322636
-
Potential therapeutic applications of recombinant, invasive E. coli
-
[105] Critchley, R., Jezzard, S., Radford, K.J., Goussard, S., Lemoine, N.R., Grillot-Courvalin, C., Vassaux, G., Potential therapeutic applications of recombinant, invasive E. coli. Gene Therapy 11 (2004), 1224–1233.
-
(2004)
Gene Therapy
, vol.11
, pp. 1224-1233
-
-
Critchley, R.1
Jezzard, S.2
Radford, K.J.3
Goussard, S.4
Lemoine, N.R.5
Grillot-Courvalin, C.6
Vassaux, G.7
-
106
-
-
40249119779
-
Bactofection of lung epithelial cells in vitro and in vivo using a genetically modified Escherichia coli
-
[106] Larsen, M.D.B., Griesenbach, U., Goussard, S., Gruenert, D.C., Geddes, D.M., Scheule, R.K., Cheng, S.H., Courvalin, P., Grillot-Courvalin, C., Alton, E.W.F.W., Bactofection of lung epithelial cells in vitro and in vivo using a genetically modified Escherichia coli. Gene Ther. 15 (2008), 434–442.
-
(2008)
Gene Ther.
, vol.15
, pp. 434-442
-
-
Larsen, M.D.B.1
Griesenbach, U.2
Goussard, S.3
Gruenert, D.C.4
Geddes, D.M.5
Scheule, R.K.6
Cheng, S.H.7
Courvalin, P.8
Grillot-Courvalin, C.9
Alton, E.W.F.W.10
-
107
-
-
84895068087
-
Effect of ultrasound irradiation on bacterial internalization and bacteria-mediated gene transfer to cancer cells
-
[107] Ninomiya, K., Yamada, R., Meisaku, H., Shimizu, N., Effect of ultrasound irradiation on bacterial internalization and bacteria-mediated gene transfer to cancer cells. Ultrason. Sonochem. 21 (2014), 1187–1193.
-
(2014)
Ultrason. Sonochem.
, vol.21
, pp. 1187-1193
-
-
Ninomiya, K.1
Yamada, R.2
Meisaku, H.3
Shimizu, N.4
-
108
-
-
84887322455
-
Polymyxin B treatment improves bactofection efficacy and reduces cytotoxicity
-
[108] Jones, C.H., Rane, S., Patt, E., Ravikrishnan, A., Chen, C.K., Cheng, C., Pfeifer, B.A., Polymyxin B treatment improves bactofection efficacy and reduces cytotoxicity. Mol. Pharm. 10 (2013), 4301–4308.
-
(2013)
Mol. Pharm.
, vol.10
, pp. 4301-4308
-
-
Jones, C.H.1
Rane, S.2
Patt, E.3
Ravikrishnan, A.4
Chen, C.K.5
Cheng, C.6
Pfeifer, B.A.7
-
109
-
-
84879202355
-
Escherichia coli bactofection using lipofectamine
-
[109] Narayanan, K., Lee, C.W., Radu, A., Sim, E.U.H., Escherichia coli bactofection using lipofectamine. Anal. Biochem. 439 (2013), 142–144.
-
(2013)
Anal. Biochem.
, vol.439
, pp. 142-144
-
-
Narayanan, K.1
Lee, C.W.2
Radu, A.3
Sim, E.U.H.4
-
110
-
-
79960032579
-
Specific antibody-receptor interactions trigger InlAB-independent uptake of listeria monocytogenes into tumor cell lines
-
[110] Heisig, M., Frentzen, A., Bergmann, B., Galmbacher, K., Gentschev, I., Hotz, C., Schoen, C., Stritzker, J., Fensterle, J., Rapp, U.R., Goebel, W., Specific antibody-receptor interactions trigger InlAB-independent uptake of listeria monocytogenes into tumor cell lines. BMC Microbiol., 11, 2011.
-
(2011)
BMC Microbiol.
, vol.11
-
-
Heisig, M.1
Frentzen, A.2
Bergmann, B.3
Galmbacher, K.4
Gentschev, I.5
Hotz, C.6
Schoen, C.7
Stritzker, J.8
Fensterle, J.9
Rapp, U.R.10
Goebel, W.11
-
111
-
-
79956102597
-
Engineering of Escherichia coli for targeted delivery of transgenes to HER2/neu-positive tumor cells
-
[111] Chang, C.H., Cheng, W.J., Chen, S.Y., Kao, M.C., Chiang, C.J., Chao, Y.P., Engineering of Escherichia coli for targeted delivery of transgenes to HER2/neu-positive tumor cells. Biotechnol. Bioeng. 108 (2011), 1662–1672.
-
(2011)
Biotechnol. Bioeng.
, vol.108
, pp. 1662-1672
-
-
Chang, C.H.1
Cheng, W.J.2
Chen, S.Y.3
Kao, M.C.4
Chiang, C.J.5
Chao, Y.P.6
-
112
-
-
84936764340
-
Surface display of an anti-DEC-205 single chain Fv fragment in Lactobacillus plantarum increases internalization and plasmid transfer to dendritic cells in vitro and in vivo
-
[112] Michon, C., Kuczkowska, K., Langella, P., Eijsink, V.G., Mathiesen, G., Chatel, J.M., Surface display of an anti-DEC-205 single chain Fv fragment in Lactobacillus plantarum increases internalization and plasmid transfer to dendritic cells in vitro and in vivo. Microb. Cell Factories, 14, 2015, 95.
-
(2015)
Microb. Cell Factories
, vol.14
, pp. 95
-
-
Michon, C.1
Kuczkowska, K.2
Langella, P.3
Eijsink, V.G.4
Mathiesen, G.5
Chatel, J.M.6
-
113
-
-
42549170951
-
Prodrug converting enzyme gene delivery by L-monocytogenes
-
[113] Stritzker, J., Pilgrim, S., Szalay, A.A., Goebel, W., Prodrug converting enzyme gene delivery by L-monocytogenes. BMC Cancer, 8, 2008.
-
(2008)
BMC Cancer
, vol.8
-
-
Stritzker, J.1
Pilgrim, S.2
Szalay, A.A.3
Goebel, W.4
-
114
-
-
84868484767
-
The future of human DNA vaccines
-
[114] Li, L., Saade, F., Petrovsky, N., The future of human DNA vaccines. J. Biotechnol. 162 (2012), 171–182.
-
(2012)
J. Biotechnol.
, vol.162
, pp. 171-182
-
-
Li, L.1
Saade, F.2
Petrovsky, N.3
-
115
-
-
84906794766
-
Recent developments in preclinical DNA vaccination
-
[115] Okuda, K., Wada, Y., Shimada, M., Recent developments in preclinical DNA vaccination. Vaccines (Basel) 2 (2014), 89–106.
-
(2014)
Vaccines (Basel)
, vol.2
, pp. 89-106
-
-
Okuda, K.1
Wada, Y.2
Shimada, M.3
-
116
-
-
78650518250
-
A live attenuated Listeria monocytogenes vaccine vector expressing SIV Gag is safe and immunogenic in macaques and can be administered repeatedly
-
[116] Sciaranghella, G., Lakhashe, S.K., Ayash-Rashkovsky, M., Mirshahidi, S., Siddappa, N.B., Novembre, F.J., Velu, V., Amara, R.R., Zhou, C.H., Li, S.F., Li, Z.X., Frankel, F.R., Ruprecht, R.M., A live attenuated Listeria monocytogenes vaccine vector expressing SIV Gag is safe and immunogenic in macaques and can be administered repeatedly. Vaccine 29 (2011), 476–486.
-
(2011)
Vaccine
, vol.29
, pp. 476-486
-
-
Sciaranghella, G.1
Lakhashe, S.K.2
Ayash-Rashkovsky, M.3
Mirshahidi, S.4
Siddappa, N.B.5
Novembre, F.J.6
Velu, V.7
Amara, R.R.8
Zhou, C.H.9
Li, S.F.10
Li, Z.X.11
Frankel, F.R.12
Ruprecht, R.M.13
-
117
-
-
0035925630
-
Recombinant attenuated bacteria for the delivery of subunit vaccines
-
[117] Gentschev, I., Dietrich, G., Spreng, S., Kolb-Maurer, A., Brinkmann, V., Grode, L., Hess, J., Kaufmann, S.H.E., Goebel, W., Recombinant attenuated bacteria for the delivery of subunit vaccines. Vaccine 19 (2001), 2621–2628.
-
(2001)
Vaccine
, vol.19
, pp. 2621-2628
-
-
Gentschev, I.1
Dietrich, G.2
Spreng, S.3
Kolb-Maurer, A.4
Brinkmann, V.5
Grode, L.6
Hess, J.7
Kaufmann, S.H.E.8
Goebel, W.9
-
118
-
-
61849090915
-
Cancer immunotherapy using Listeria monocytogenes and listerial virulence factors
-
[118] Wood, L.M., Guirnalda, P.D., Seavey, M.M., Paterson, Y., Cancer immunotherapy using Listeria monocytogenes and listerial virulence factors. Immunol. Res. 42 (2008), 233–245.
-
(2008)
Immunol. Res.
, vol.42
, pp. 233-245
-
-
Wood, L.M.1
Guirnalda, P.D.2
Seavey, M.M.3
Paterson, Y.4
-
119
-
-
0036847666
-
A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: Application to cancer immunotherapy
-
[119] Radford, K.J., Higgins, D.E., Pasquini, S., Cheadle, E.J., Carta, L., Jackson, A.M., Lemoine, N.R., Vassaux, G., A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: Application to cancer immunotherapy. Gene Ther. 9 (2002), 1455–1463.
-
(2002)
Gene Ther.
, vol.9
, pp. 1455-1463
-
-
Radford, K.J.1
Higgins, D.E.2
Pasquini, S.3
Cheadle, E.J.4
Carta, L.5
Jackson, A.M.6
Lemoine, N.R.7
Vassaux, G.8
-
120
-
-
84879348192
-
Therapeutic DNA vaccination and RNA interference in inflammatory bowel disease
-
[120] Gardlik, R., Bartonova, A., Celec, P., Therapeutic DNA vaccination and RNA interference in inflammatory bowel disease. Int. J. Mol. Med. 32 (2013), 492–496.
-
(2013)
Int. J. Mol. Med.
, vol.32
, pp. 492-496
-
-
Gardlik, R.1
Bartonova, A.2
Celec, P.3
-
121
-
-
77957727848
-
Bacterial vectors and delivery systems in cancer therapy
-
[121] Gardlik, R., Fruehauf, J.H., Bacterial vectors and delivery systems in cancer therapy. IDrugs 13 (2010), 701–706.
-
(2010)
IDrugs
, vol.13
, pp. 701-706
-
-
Gardlik, R.1
Fruehauf, J.H.2
-
122
-
-
13444303995
-
Systemic administration of attenuated Salmonella choleraesuis carrying thrombospondin-1 gene leads to tumor-specific transgene expression, delayed tumor growth and prolonged survival in the murine melanoma model
-
[122] Lee, C.H., Wu, C.L., Shiau, A.L., Systemic administration of attenuated Salmonella choleraesuis carrying thrombospondin-1 gene leads to tumor-specific transgene expression, delayed tumor growth and prolonged survival in the murine melanoma model. Cancer Gene Ther. 12 (2005), 175–184.
-
(2005)
Cancer Gene Ther.
, vol.12
, pp. 175-184
-
-
Lee, C.H.1
Wu, C.L.2
Shiau, A.L.3
-
123
-
-
0242524492
-
Bactofection of mammalian cells by Listeria monocytogenes: improvement and mechanism of DNA delivery
-
[123] Pilgrim, S., Stritzker, J., Schoen, C., Kolb-Maurer, A., Geginat, G., Loessner, M.J., Gentschev, I., Goebel, W., Bactofection of mammalian cells by Listeria monocytogenes: improvement and mechanism of DNA delivery. Gene Ther. 10 (2003), 2036–2045.
-
(2003)
Gene Ther.
, vol.10
, pp. 2036-2045
-
-
Pilgrim, S.1
Stritzker, J.2
Schoen, C.3
Kolb-Maurer, A.4
Geginat, G.5
Loessner, M.J.6
Gentschev, I.7
Goebel, W.8
-
124
-
-
46649110349
-
Synergistic antitumoral effects of human telomerase reverse transcriptase-mediated dual-apoptosis-related gene vector delivered by orally attenuated Salmonella enterica Serovar typhimurium in murine tumor models
-
[124] Fu, W., Chu, L., Han, X., Liu, X., Ren, D., Synergistic antitumoral effects of human telomerase reverse transcriptase-mediated dual-apoptosis-related gene vector delivered by orally attenuated Salmonella enterica Serovar typhimurium in murine tumor models. J. Gene Med. 10 (2008), 690–701.
-
(2008)
J. Gene Med.
, vol.10
, pp. 690-701
-
-
Fu, W.1
Chu, L.2
Han, X.3
Liu, X.4
Ren, D.5
-
125
-
-
70449533849
-
Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice
-
[125] Ganai, S., Arenas, R., Forbes, N., Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice. Br. J. Cancer 101 (2009), 1683–1691.
-
(2009)
Br. J. Cancer
, vol.101
, pp. 1683-1691
-
-
Ganai, S.1
Arenas, R.2
Forbes, N.3
-
126
-
-
79951596110
-
Salmonella-mediated gene therapy in experimental colitis in mice
-
[126] Palffy, R., Gardlik, R., Behuliak, M., Jani, P., Balakova, D., Kadasi, L., Turna, J., Celec, P., Salmonella-mediated gene therapy in experimental colitis in mice. Exp. Biol. Med. 236 (2011), 177–183.
-
(2011)
Exp. Biol. Med.
, vol.236
, pp. 177-183
-
-
Palffy, R.1
Gardlik, R.2
Behuliak, M.3
Jani, P.4
Balakova, D.5
Kadasi, L.6
Turna, J.7
Celec, P.8
-
127
-
-
84903266584
-
Effects of bacteria-mediated reprogramming and antibiotic pretreatment on the course of colitis in mice
-
[127] Gardlik, R., Wagnerova, A., Celec, P., Effects of bacteria-mediated reprogramming and antibiotic pretreatment on the course of colitis in mice. Mol. Med. Rep. 10 (2014), 983–988.
-
(2014)
Mol. Med. Rep.
, vol.10
, pp. 983-988
-
-
Gardlik, R.1
Wagnerova, A.2
Celec, P.3
-
128
-
-
33745085925
-
Short hairpin RNA-expressing bacteria elicit RNA interference in mammals
-
[128] Xiang, S., Fruehauf, J., Li, C.J., Short hairpin RNA-expressing bacteria elicit RNA interference in mammals. Nat. Biotechnol. 24 (2006), 697–702.
-
(2006)
Nat. Biotechnol.
, vol.24
, pp. 697-702
-
-
Xiang, S.1
Fruehauf, J.2
Li, C.J.3
-
129
-
-
34250857547
-
Intratumoral delivery and suppression of prostate tumor growth by attenuated Salmonella enterica serovar typhimurium carrying plasmid-based small interfering RNAs
-
[129] Zhang, L., Gao, L.F., Zhao, L.J., Guo, B.F., Ji, K., Tian, Y., Wang, J.G., Yu, H., Hu, J.D., Kalvakolanu, D.V., Kopecko, D.J., Zhao, X.J., Xu, D.Q., Intratumoral delivery and suppression of prostate tumor growth by attenuated Salmonella enterica serovar typhimurium carrying plasmid-based small interfering RNAs. Cancer Res. 67 (2007), 5859–5864.
-
(2007)
Cancer Res.
, vol.67
, pp. 5859-5864
-
-
Zhang, L.1
Gao, L.F.2
Zhao, L.J.3
Guo, B.F.4
Ji, K.5
Tian, Y.6
Wang, J.G.7
Yu, H.8
Hu, J.D.9
Kalvakolanu, D.V.10
Kopecko, D.J.11
Zhao, X.J.12
Xu, D.Q.13
-
130
-
-
79953760330
-
Glycomimicry: display of fucosylation on the lipo-oligosaccharide of recombinant Escherichia coli K12
-
[130] Yavuz, E., Maffioli, C., Ilg, K., Aebi, M., Priem, B., Glycomimicry: display of fucosylation on the lipo-oligosaccharide of recombinant Escherichia coli K12. Glycoconj. J. 28 (2011), 39–47.
-
(2011)
Glycoconj. J.
, vol.28
, pp. 39-47
-
-
Yavuz, E.1
Maffioli, C.2
Ilg, K.3
Aebi, M.4
Priem, B.5
-
131
-
-
77956531782
-
Glycomimicry: display of the GM3 sugar epitope on Escherichia coli and Salmonella enterica sv typhimurium
-
[131] Ilg, K., Yavuz, E., Maffioli, C., Priem, B., Aebi, M., Glycomimicry: display of the GM3 sugar epitope on Escherichia coli and Salmonella enterica sv typhimurium. Glycobiology 20 (2010), 1289–1297.
-
(2010)
Glycobiology
, vol.20
, pp. 1289-1297
-
-
Ilg, K.1
Yavuz, E.2
Maffioli, C.3
Priem, B.4
Aebi, M.5
-
132
-
-
33646007668
-
Designer probiotics for prevention of enteric infections
-
[132] Paton, A.W., Morona, R., Paton, J.C., Designer probiotics for prevention of enteric infections. Nat. Rev. Microbiol. 4 (2006), 193–200.
-
(2006)
Nat. Rev. Microbiol.
, vol.4
, pp. 193-200
-
-
Paton, A.W.1
Morona, R.2
Paton, J.C.3
-
133
-
-
80955166936
-
German outbreak of Escherichia coli O104: H4 associated with sprouts
-
[133] Buchholz, U., Bernard, H., Werber, D., Böhmer, M.M., Remschmidt, C., Wilking, H., Deleré, Y., der Heiden, M.a., Adlhoch, C., Dreesman, J., German outbreak of Escherichia coli O104: H4 associated with sprouts. N. Engl. J. Med., 365(2011), 1763-1770.
-
(1763)
N. Engl. J. Med.
, vol.365
, Issue.2011
-
-
Buchholz, U.1
Bernard, H.2
Werber, D.3
Böhmer, M.M.4
Remschmidt, C.5
Wilking, H.6
Deleré, Y.7
der Heiden, M.A.8
Adlhoch, C.9
Dreesman, J.10
-
134
-
-
0034059721
-
A new biological agent for treatment of Shiga toxigenic Escherichia coli infections and dysentery in humans
-
[134] Paton, A.W., Morona, R., Paton, J.C., A new biological agent for treatment of Shiga toxigenic Escherichia coli infections and dysentery in humans. Nat. Med. 6 (2000), 265–270.
-
(2000)
Nat. Med.
, vol.6
, pp. 265-270
-
-
Paton, A.W.1
Morona, R.2
Paton, J.C.3
-
135
-
-
33646352688
-
A recombinant probiotic for treatment and prevention of cholera
-
[135] Focareta, A., Paton, J.C., Morona, R., Cook, J., Paton, A.W., A recombinant probiotic for treatment and prevention of cholera. Gastroenterology 130 (2006), 1688–1695.
-
(2006)
Gastroenterology
, vol.130
, pp. 1688-1695
-
-
Focareta, A.1
Paton, J.C.2
Morona, R.3
Cook, J.4
Paton, A.W.5
-
136
-
-
19044375218
-
Recombinant probiotics for treatment and prevention of enterotoxigenic Escherichia coli diarrhea
-
[136] Paton, A.W., Jennings, M.P., Morona, R., Wang, H., Focareta, A., Roddam, L.F., Paton, J.C., Recombinant probiotics for treatment and prevention of enterotoxigenic Escherichia coli diarrhea. Gastroenterology 128 (2005), 1219–1228.
-
(2005)
Gastroenterology
, vol.128
, pp. 1219-1228
-
-
Paton, A.W.1
Jennings, M.P.2
Morona, R.3
Wang, H.4
Focareta, A.5
Roddam, L.F.6
Paton, J.C.7
-
137
-
-
0034628502
-
Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands
-
[137] Kitov, P.I., Sadowska, J.M., Mulvey, G., Armstrong, G.D., Ling, H., Pannu, N.S., Read, R.J., Bundle, D.R., Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands. Nature 403 (2000), 669–672.
-
(2000)
Nature
, vol.403
, pp. 669-672
-
-
Kitov, P.I.1
Sadowska, J.M.2
Mulvey, G.3
Armstrong, G.D.4
Ling, H.5
Pannu, N.S.6
Read, R.J.7
Bundle, D.R.8
-
138
-
-
0004268763
-
Bacterial Stress Responses
-
2nd ed. American Society for Microbiology Press
-
[138] Storz, G., Hengge, R., Bacterial Stress Responses. 2nd ed., 2010, American Society for Microbiology Press.
-
(2010)
-
-
Storz, G.1
Hengge, R.2
-
139
-
-
78650910535
-
Optogenetics: controlling cell function with light
-
[139] Pastrana, E., Optogenetics: controlling cell function with light. Nat. Methods 8 (2011), 24–25.
-
(2011)
Nat. Methods
, vol.8
, pp. 24-25
-
-
Pastrana, E.1
-
140
-
-
84894057197
-
An optogenetic gene expression system with rapid activation and deactivation kinetics
-
[140] Motta-Mena, L.B., Reade, A., Mallory, M.J., Glantz, S., Weiner, O.D., Lynch, K.W., Gardner, K.H., An optogenetic gene expression system with rapid activation and deactivation kinetics. Nat. Chem. Biol. 10 (2014), 196–202.
-
(2014)
Nat. Chem. Biol.
, vol.10
, pp. 196-202
-
-
Motta-Mena, L.B.1
Reade, A.2
Mallory, M.J.3
Glantz, S.4
Weiner, O.D.5
Lynch, K.W.6
Gardner, K.H.7
-
141
-
-
84925534357
-
A light-inducible CRISPR-Cas9 system for control of endogenous gene activation
-
[141] Polstein, L.R., Gersbach, C.A., A light-inducible CRISPR-Cas9 system for control of endogenous gene activation. Nat. Chem. Biol. 11 (2015), 198–200.
-
(2015)
Nat. Chem. Biol.
, vol.11
, pp. 198-200
-
-
Polstein, L.R.1
Gersbach, C.A.2
-
142
-
-
84902823142
-
Optogenetic characterization methods overcome key challenges in synthetic and systems biology
-
[142] Olson, E.J., Tabor, J.J., Optogenetic characterization methods overcome key challenges in synthetic and systems biology. Nat. Chem. Biol. 10 (2014), 502–511.
-
(2014)
Nat. Chem. Biol.
, vol.10
, pp. 502-511
-
-
Olson, E.J.1
Tabor, J.J.2
-
143
-
-
81555201174
-
Bacterial magnetosome: a novel biogenetic magnetic targeted drug carrier with potential multifunctions
-
[143] Sun, J., Li, Y., Liang, X.-J., Wang, P.C., Bacterial magnetosome: a novel biogenetic magnetic targeted drug carrier with potential multifunctions. J. Nanomater., 2011, 2011, 9.
-
(2011)
J. Nanomater.
, vol.2011
, pp. 9
-
-
Sun, J.1
Li, Y.2
Liang, X.-J.3
Wang, P.C.4
-
144
-
-
57349106491
-
Magnetotactic bacteria and magnetosomes
-
[144] Faivre, D., Schüler, D., Magnetotactic bacteria and magnetosomes. Chem. Rev. 108 (2008), 4875–4898.
-
(2008)
Chem. Rev.
, vol.108
, pp. 4875-4898
-
-
Faivre, D.1
Schüler, D.2
-
145
-
-
84890559727
-
Assessment of navigation control strategy for magnetotactic bacteria in microchannel: Toward targeting solid tumors
-
[145] Felfoul, O., Martel, S., Assessment of navigation control strategy for magnetotactic bacteria in microchannel: Toward targeting solid tumors. Biomed. Microdevices 15 (2013), 1015–1024.
-
(2013)
Biomed. Microdevices
, vol.15
, pp. 1015-1024
-
-
Felfoul, O.1
Martel, S.2
-
146
-
-
84920709042
-
Construction of a microrobot system using magnetotactic bacteria for the separation of Staphylococcus aureus
-
[146] Chen, C.-Y., Chen, C.-F., Yi, Y., Chen, L.-J., Wu, L.-F., Song, T., Construction of a microrobot system using magnetotactic bacteria for the separation of Staphylococcus aureus. Biomed. Microdevices 16 (2014), 761–770.
-
(2014)
Biomed. Microdevices
, vol.16
, pp. 761-770
-
-
Chen, C.-Y.1
Chen, C.-F.2
Yi, Y.3
Chen, L.-J.4
Wu, L.-F.5
Song, T.6
-
147
-
-
34047171440
-
Towards MRI-controlled ferromagnetic and MC-1 magnetotactic bacterial carriers for targeted therapies in arteriolocapillar networks stimulated by tumoral angiogenesis, Engineering in Medicine and Biology Society, 2006
-
[147] Martel, S., Towards MRI-controlled ferromagnetic and MC-1 magnetotactic bacterial carriers for targeted therapies in arteriolocapillar networks stimulated by tumoral angiogenesis, Engineering in Medicine and Biology Society, 2006. EMBS'06. 28th Annual International Conference of the IEEE, IEEE, 2006, 3399–3402.
-
(2006)
EMBS'06. 28th Annual International Conference of the IEEE, IEEE
, pp. 3399-3402
-
-
Martel, S.1
-
148
-
-
84982128186
-
Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions
-
(advance online publication)
-
[148] Felfoul, O., Mohammadi, M., Taherkhani, S., de Lanauze, D., Zhong Xu, Y., Loghin, D., Essa, S., Jancik, S., Houle, D., Lafleur, M., Gaboury, L., Tabrizian, M., Kaou, N., Atkin, M., Vuong, T., Batist, G., Beauchemin, N., Radzioch, D., Martel, S., Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions. Nat. Nanotechnol., 2016 (advance online publication).
-
(2016)
Nat. Nanotechnol.
-
-
Felfoul, O.1
Mohammadi, M.2
Taherkhani, S.3
de Lanauze, D.4
Zhong Xu, Y.5
Loghin, D.6
Essa, S.7
Jancik, S.8
Houle, D.9
Lafleur, M.10
Gaboury, L.11
Tabrizian, M.12
Kaou, N.13
Atkin, M.14
Vuong, T.15
Batist, G.16
Beauchemin, N.17
Radzioch, D.18
Martel, S.19
-
149
-
-
84870780041
-
Bacterial magnetic particles as a novel and efficient gene vaccine delivery system
-
[149] Tang, Y.S., Wang, D., Zhou, C., Ma, W., Zhang, Y.Q., Liu, B., Zhang, S., Bacterial magnetic particles as a novel and efficient gene vaccine delivery system. Gene Ther. 19 (2012), 1187–1195.
-
(2012)
Gene Ther.
, vol.19
, pp. 1187-1195
-
-
Tang, Y.S.1
Wang, D.2
Zhou, C.3
Ma, W.4
Zhang, Y.Q.5
Liu, B.6
Zhang, S.7
-
150
-
-
2942590732
-
Exploiting tumour hypoxia in cancer treatment
-
[150] Brown, J.M., Wilson, W.R., Exploiting tumour hypoxia in cancer treatment. Nat. Rev. Cancer 4 (2004), 437–447.
-
(2004)
Nat. Rev. Cancer
, vol.4
, pp. 437-447
-
-
Brown, J.M.1
Wilson, W.R.2
-
151
-
-
0242331755
-
HIF-1 as a target for drug development
-
[151] Giaccia, A., Siim, B.G., Johnson, R.S., HIF-1 as a target for drug development. Nat. Rev. Drug Discov. 2 (2003), 803–811.
-
(2003)
Nat. Rev. Drug Discov.
, vol.2
, pp. 803-811
-
-
Giaccia, A.1
Siim, B.G.2
Johnson, R.S.3
-
152
-
-
0142166332
-
Targeting HIF-1 for cancer therapy
-
[152] Semenza, G.L., Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3 (2003), 721–732.
-
(2003)
Nat. Rev. Cancer
, vol.3
, pp. 721-732
-
-
Semenza, G.L.1
-
153
-
-
0030865697
-
Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment
-
[153] Lemmon, M.J., Van Zijl, P., Fox, M.E., Mauchline, M.L., Giaccia, A.J., Minton, N.P., Brown, J.M., Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment. Gene Ther. 4 (1997), 791–796.
-
(1997)
Gene Ther.
, vol.4
, pp. 791-796
-
-
Lemmon, M.J.1
Van Zijl, P.2
Fox, M.E.3
Mauchline, M.L.4
Giaccia, A.J.5
Minton, N.P.6
Brown, J.M.7
-
154
-
-
0029932035
-
Anaerobic bacteria as a delivery system for cancer gene therapy: in vitro activation of 5-fluorocytosine by genetically engineered clostridia
-
[154] Fox, M.E., Lemmon, M.J., Mauchline, M.L., Davis, T.O., Giaccia, A.J., Minton, N.P., Brown, J.M., Anaerobic bacteria as a delivery system for cancer gene therapy: in vitro activation of 5-fluorocytosine by genetically engineered clostridia. Gene Ther. 3 (1996), 173–178.
-
(1996)
Gene Ther.
, vol.3
, pp. 173-178
-
-
Fox, M.E.1
Lemmon, M.J.2
Mauchline, M.L.3
Davis, T.O.4
Giaccia, A.J.5
Minton, N.P.6
Brown, J.M.7
-
155
-
-
34247618171
-
Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice
-
[155] Stritzker, J., Weibel, S., Hill, P.J., Oelschlaeger, T.A., Goebel, W., Szalay, A.A., Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice. Int J Med Microbiol 297 (2007), 151–162.
-
(2007)
Int J Med Microbiol
, vol.297
, pp. 151-162
-
-
Stritzker, J.1
Weibel, S.2
Hill, P.J.3
Oelschlaeger, T.A.4
Goebel, W.5
Szalay, A.A.6
-
156
-
-
29144482539
-
Environmentally controlled invasion of cancer cells by engineered bacteria
-
[156] Anderson, J.C., Clarke, E.J., Arkin, A.P., Voigt, C.A., Environmentally controlled invasion of cancer cells by engineered bacteria. J. Mol. Biol. 355 (2006), 619–627.
-
(2006)
J. Mol. Biol.
, vol.355
, pp. 619-627
-
-
Anderson, J.C.1
Clarke, E.J.2
Arkin, A.P.3
Voigt, C.A.4
-
157
-
-
33745085925
-
Short hairpin RNA–expressing bacteria elicit RNA interference in mammals
-
[157] Xiang, S., Fruehauf, J., Li, C.J., Short hairpin RNA–expressing bacteria elicit RNA interference in mammals. Nat. Biotechnol. 24 (2006), 697–702.
-
(2006)
Nat. Biotechnol.
, vol.24
, pp. 697-702
-
-
Xiang, S.1
Fruehauf, J.2
Li, C.J.3
-
158
-
-
42549114845
-
Oral administration of attenuated S. typhimurium carrying shRNA-expressing vectors as a cancer therapeutic
-
[158] Yang, N., Zhu, X., Chen, L., Li, S., Ren, D., Oral administration of attenuated S. typhimurium carrying shRNA-expressing vectors as a cancer therapeutic. Cancer Biol. Ther. 7 (2008), 145–151.
-
(2008)
Cancer Biol. Ther.
, vol.7
, pp. 145-151
-
-
Yang, N.1
Zhu, X.2
Chen, L.3
Li, S.4
Ren, D.5
-
159
-
-
56049102354
-
IL-18-producing Salmonella inhibit tumor growth
-
[159] Loeffler, M., Le'Negrate, G., Krajewska, M., Reed, J.C., IL-18-producing Salmonella inhibit tumor growth. Cancer Gene Ther. 15 (2008), 787–794.
-
(2008)
Cancer Gene Ther.
, vol.15
, pp. 787-794
-
-
Loeffler, M.1
Le'Negrate, G.2
Krajewska, M.3
Reed, J.C.4
-
160
-
-
61349195788
-
Salmonella typhimurium engineered to produce CCL21 inhibit tumor growth
-
[160] Loeffler, M., Le'Negrate, G., Krajewska, M., Reed, J.C., Salmonella typhimurium engineered to produce CCL21 inhibit tumor growth. Cancer Immunol. Immunother. 58 (2009), 769–775.
-
(2009)
Cancer Immunol. Immunother.
, vol.58
, pp. 769-775
-
-
Loeffler, M.1
Le'Negrate, G.2
Krajewska, M.3
Reed, J.C.4
-
161
-
-
34547865745
-
Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth
-
[161] Loeffler, M., Le'Negrate, G., Krajewska, M., Reed, J.C., Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth. Proc. Natl. Acad. Sci. 104 (2007), 12879–12883.
-
(2007)
Proc. Natl. Acad. Sci.
, vol.104
, pp. 12879-12883
-
-
Loeffler, M.1
Le'Negrate, G.2
Krajewska, M.3
Reed, J.C.4
-
162
-
-
77956212249
-
Tumor pH and its measurement
-
[162] Zhang, X., Lin, Y., Gillies, R.J., Tumor pH and its measurement. J. Nucl. Med. 51 (2010), 1167–1170.
-
(2010)
J. Nucl. Med.
, vol.51
, pp. 1167-1170
-
-
Zhang, X.1
Lin, Y.2
Gillies, R.J.3
-
163
-
-
0018425724
-
Fever and reduced iron: their interaction as a host defense response to bacterial infection
-
[163] Kluger, M., Rothenburg, B., Fever and reduced iron: their interaction as a host defense response to bacterial infection. Science 203 (1979), 374–376.
-
(1979)
Science
, vol.203
, pp. 374-376
-
-
Kluger, M.1
Rothenburg, B.2
-
164
-
-
84931274888
-
pH-taxis of biohybrid microsystems
-
[164] Zhuang, J., Wright Carlsen, R., Sitti, M., pH-taxis of biohybrid microsystems. Sci. Report., 5, 2015, 11403.
-
(2015)
Sci. Report.
, vol.5
, pp. 11403
-
-
Zhuang, J.1
Wright Carlsen, R.2
Sitti, M.3
-
165
-
-
84868351671
-
Thermal control of microbial development and virulence: molecular mechanisms of microbial temperature sensing
-
[165] Shapiro, R.S., Cowen, L.E., Thermal control of microbial development and virulence: molecular mechanisms of microbial temperature sensing. mBio, 3, 2012.
-
(2012)
mBio
, vol.3
-
-
Shapiro, R.S.1
Cowen, L.E.2
-
166
-
-
0036260547
-
Regulation of bacterial motility in response to low pH in Escherichia coli: the role of H-NS protein
-
[166] Soutourina, O.A., Krin, E., Laurent-Winter, C., Hommais, F., Danchin, A., Bertin, P.N., Regulation of bacterial motility in response to low pH in Escherichia coli: the role of H-NS protein. Microbiology 148 (2002), 1543–1551.
-
(2002)
Microbiology
, vol.148
, pp. 1543-1551
-
-
Soutourina, O.A.1
Krin, E.2
Laurent-Winter, C.3
Hommais, F.4
Danchin, A.5
Bertin, P.N.6
-
167
-
-
84937699000
-
Escherichia coli Nissle 1917 bacterial ghosts retain crucial surface properties and express chlamydial antigen: an imaging study of a delivery system for the ocular surface
-
[167] Montanaro, J., Inic-Kanada, A., Ladurner, A., Stein, E., Belij, S., Bintner, N., Schlacher, S., Schuerer, N., Mayr, U.B., Lubitz, W., Leisch, N., Barisani-Asenbauer, T., Escherichia coli Nissle 1917 bacterial ghosts retain crucial surface properties and express chlamydial antigen: an imaging study of a delivery system for the ocular surface. Drug Des. Devel. Ther. 9 (2015), 3741–3754.
-
(2015)
Drug Des. Devel. Ther.
, vol.9
, pp. 3741-3754
-
-
Montanaro, J.1
Inic-Kanada, A.2
Ladurner, A.3
Stein, E.4
Belij, S.5
Bintner, N.6
Schlacher, S.7
Schuerer, N.8
Mayr, U.B.9
Lubitz, W.10
Leisch, N.11
Barisani-Asenbauer, T.12
-
168
-
-
78449290476
-
The bacterial ghost platform system: production and applications
-
[168] Langemann, T., Koller, V.J., Muhammad, A., Kudela, P., Mayr, U.B., Lubitz, W., The bacterial ghost platform system: production and applications. Bioengineered Bugs 1 (2010), 326–336.
-
(2010)
Bioengineered Bugs
, vol.1
, pp. 326-336
-
-
Langemann, T.1
Koller, V.J.2
Muhammad, A.3
Kudela, P.4
Mayr, U.B.5
Lubitz, W.6
-
169
-
-
0019900680
-
Lysis of Escherichia coli by induction of cloned phi X174 genes
-
[169] Henrich, B., Lubitz, W., Plapp, R., Lysis of Escherichia coli by induction of cloned phi X174 genes. Mol. Gen. Genet. MGG 185 (1982), 493–497.
-
(1982)
Mol. Gen. Genet. MGG
, vol.185
, pp. 493-497
-
-
Henrich, B.1
Lubitz, W.2
Plapp, R.3
-
170
-
-
0024603427
-
Evidence for membrane-bound oligomerization of bacteriophage phi X174 lysis protein-E
-
[170] Bläsi, U., Linke, R.P., Lubitz, W., Evidence for membrane-bound oligomerization of bacteriophage phi X174 lysis protein-E. J. Biol. Chem. 264 (1989), 4552–4558.
-
(1989)
J. Biol. Chem.
, vol.264
, pp. 4552-4558
-
-
Bläsi, U.1
Linke, R.P.2
Lubitz, W.3
-
171
-
-
0024477877
-
Biochemical characterization of phiX174-protein-E-mediated lysis of Escherichia coli
-
[171] Witte, A., Lubitz, W., Biochemical characterization of phiX174-protein-E-mediated lysis of Escherichia coli. Eur. J. Biochem. 180 (1989), 393–398.
-
(1989)
Eur. J. Biochem.
, vol.180
, pp. 393-398
-
-
Witte, A.1
Lubitz, W.2
-
172
-
-
0026535978
-
Dynamics of PhiX174 protein E-mediated lysis of Escherichia coli
-
[172] Witte, A., Wanner, G., Sulzner, M., Lubitz, W., Dynamics of PhiX174 protein E-mediated lysis of Escherichia coli. Arch. Microbiol. 157 (1992), 381–388.
-
(1992)
Arch. Microbiol.
, vol.157
, pp. 381-388
-
-
Witte, A.1
Wanner, G.2
Sulzner, M.3
Lubitz, W.4
-
173
-
-
9244232283
-
Bacterial ghosts — biological particles as delivery systems for antigens, nucleic acids and drugs
-
[173] Tabrizi, C.A., Walcher, P., Mayr, U.B., Stiedl, T., Binder, M., McGrath, J., Lubitz, W., Bacterial ghosts — biological particles as delivery systems for antigens, nucleic acids and drugs. Curr. Opin. Biotechnol. 15 (2004), 530–537.
-
(2004)
Curr. Opin. Biotechnol.
, vol.15
, pp. 530-537
-
-
Tabrizi, C.A.1
Walcher, P.2
Mayr, U.B.3
Stiedl, T.4
Binder, M.5
McGrath, J.6
Lubitz, W.7
-
174
-
-
0032858607
-
Bacterial ghosts as drug carrier and targeting vehicles
-
[174] Huter, V., Szostak, M.P., Gampfer, J., Prethaler, S., Wanner, G., Gabor, F., Lubitz, W., Bacterial ghosts as drug carrier and targeting vehicles. J. Control. Release 61 (1999), 51–63.
-
(1999)
J. Control. Release
, vol.61
, pp. 51-63
-
-
Huter, V.1
Szostak, M.P.2
Gampfer, J.3
Prethaler, S.4
Wanner, G.5
Gabor, F.6
Lubitz, W.7
-
175
-
-
0034730708
-
Activation, stimulation and uptake of bacterial ghosts in antigen presenting cells
-
[175] Haslberger, A.G., Kohl, G., Felnerova, D., Mayr, U.B., Fürst-Ladani, S., Lubitz, W., Activation, stimulation and uptake of bacterial ghosts in antigen presenting cells. J. Biotechnol. 83 (2000), 57–66.
-
(2000)
J. Biotechnol.
, vol.83
, pp. 57-66
-
-
Haslberger, A.G.1
Kohl, G.2
Felnerova, D.3
Mayr, U.B.4
Fürst-Ladani, S.5
Lubitz, W.6
-
176
-
-
0141920347
-
Sealed bacterial ghosts—novel targeting vehicles for advanced drug delivery of water-soluble substances
-
[176] Paukner, S., Kohl, G., Jalava, K., Lubitz, W., Sealed bacterial ghosts—novel targeting vehicles for advanced drug delivery of water-soluble substances. J. Drug Target. 11 (2003), 151–161.
-
(2003)
J. Drug Target.
, vol.11
, pp. 151-161
-
-
Paukner, S.1
Kohl, G.2
Jalava, K.3
Lubitz, W.4
-
177
-
-
0346735300
-
Bacterial ghosts as novel advanced drug delivery systems: antiproliferative activity of loaded doxorubicin in human Caco-2 cells
-
[177] Paukner, S., Kohl, G., Lubitz, W., Bacterial ghosts as novel advanced drug delivery systems: antiproliferative activity of loaded doxorubicin in human Caco-2 cells. J. Control. Release 94 (2004), 63–74.
-
(2004)
J. Control. Release
, vol.94
, pp. 63-74
-
-
Paukner, S.1
Kohl, G.2
Lubitz, W.3
-
178
-
-
84884540406
-
In vitro and in vivo uptake study of Escherichia coli Nissle 1917 bacterial ghosts: cell-based delivery system to target ocular surface diseases
-
[178] Stein, E., Inic-Kanada, A., Belij, S., Montanaro, J., Bintner, N., Schlacher, S., Mayr, U.B., Lubitz, W., Stojanovic, M., Najdenski, H., Barisani-Asenbauer, T., In vitro and in vivo uptake study of Escherichia coli Nissle 1917 bacterial ghosts: cell-based delivery system to target ocular surface diseases. Invest. Ophthalmol. Vis. Sci. 54 (2013), 6326–6333.
-
(2013)
Invest. Ophthalmol. Vis. Sci.
, vol.54
, pp. 6326-6333
-
-
Stein, E.1
Inic-Kanada, A.2
Belij, S.3
Montanaro, J.4
Bintner, N.5
Schlacher, S.6
Mayr, U.B.7
Lubitz, W.8
Stojanovic, M.9
Najdenski, H.10
Barisani-Asenbauer, T.11
-
179
-
-
84874496513
-
Modulation of bacterial ghosts—induced nitric oxide production in macrophages by bacterial ghost-delivered resveratrol
-
[179] Koller, V.J., Dirsch, V.M., Beres, H., Donath, O., Reznicek, G., Lubitz, W., Kudela, P., Modulation of bacterial ghosts—induced nitric oxide production in macrophages by bacterial ghost-delivered resveratrol. FEBS J. 280 (2013), 1214–1225.
-
(2013)
FEBS J.
, vol.280
, pp. 1214-1225
-
-
Koller, V.J.1
Dirsch, V.M.2
Beres, H.3
Donath, O.4
Reznicek, G.5
Lubitz, W.6
Kudela, P.7
-
180
-
-
0003152858
-
Miniature Escherichia coli cells deficient in DNA
-
[180] Adler, H.I., Fisher, W.D., Cohen, A., Hardigree, A.A., Miniature Escherichia coli cells deficient in DNA. Proc. Natl. Acad. Sci. U. S. A. 57 (1967), 321–326.
-
(1967)
Proc. Natl. Acad. Sci. U. S. A.
, vol.57
, pp. 321-326
-
-
Adler, H.I.1
Fisher, W.D.2
Cohen, A.3
Hardigree, A.A.4
-
181
-
-
78650972239
-
Self-organized partitioning of dynamically localized proteins in bacterial cell division
-
[181] Di Ventura, B., Sourjik, V., Self-organized partitioning of dynamically localized proteins in bacterial cell division. Mol. Syst. Biol., 7, 2011, 457.
-
(2011)
Mol. Syst. Biol.
, vol.7
, pp. 457
-
-
Di Ventura, B.1
Sourjik, V.2
-
182
-
-
0015898268
-
Cell growth and division in Escherichia coli: a common genetic control involved in cell division and minicell formation
-
[182] Khachatourians, G.G., Clark, D.J., Adler, H.I., Hardigree, A.A., Cell growth and division in Escherichia coli: a common genetic control involved in cell division and minicell formation. J. Bacteriol. 116 (1973), 226–229.
-
(1973)
J. Bacteriol.
, vol.116
, pp. 226-229
-
-
Khachatourians, G.G.1
Clark, D.J.2
Adler, H.I.3
Hardigree, A.A.4
-
183
-
-
0016184146
-
Replication of colicin E1 plasmid DNA in minicells from a unique replication initiation site
-
[183] Inselburg, J., Replication of colicin E1 plasmid DNA in minicells from a unique replication initiation site. Proc. Natl. Acad. Sci. U. S. A. 71 (1974), 2256–2259.
-
(1974)
Proc. Natl. Acad. Sci. U. S. A.
, vol.71
, pp. 2256-2259
-
-
Inselburg, J.1
-
184
-
-
67650479404
-
Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug
-
[184] MacDiarmid, J.A., Amaro-Mugridge, N.B., Madrid-Weiss, J., Sedliarou, I., Wetzel, S., Kochar, K., Brahmbhatt, V.N., Phillips, L., Pattison, S.T., Petti, C., Stillman, B., Graham, R.M., Brahmbhatt, H., Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug. Nat. Biotechnol. 27 (2009), 643–651.
-
(2009)
Nat. Biotechnol.
, vol.27
, pp. 643-651
-
-
MacDiarmid, J.A.1
Amaro-Mugridge, N.B.2
Madrid-Weiss, J.3
Sedliarou, I.4
Wetzel, S.5
Kochar, K.6
Brahmbhatt, V.N.7
Phillips, L.8
Pattison, S.T.9
Petti, C.10
Stillman, B.11
Graham, R.M.12
Brahmbhatt, H.13
-
185
-
-
77955557497
-
Bacterial ghosts (BGs)—advanced antigen and drug delivery system
-
[185] Kudela, P., Koller, V.J., Lubitz, W., Bacterial ghosts (BGs)—advanced antigen and drug delivery system. Vaccine 28 (2010), 5760–5767.
-
(2010)
Vaccine
, vol.28
, pp. 5760-5767
-
-
Kudela, P.1
Koller, V.J.2
Lubitz, W.3
-
186
-
-
80053471381
-
Bacterial Chemotaxis, eLS
-
John Wiley & Sons, Ltd
-
[186] Eisenbach, M., Bacterial Chemotaxis, eLS. 2001, John Wiley & Sons, Ltd.
-
(2001)
-
-
Eisenbach, M.1
-
187
-
-
65949100122
-
Miniature devices voyage of the microrobots
-
[187] Sitti, M., Miniature devices voyage of the microrobots. Nature 458 (2009), 1121–1122.
-
(2009)
Nature
, vol.458
, pp. 1121-1122
-
-
Sitti, M.1
-
188
-
-
34147147591
-
Microscale and nanoscale robotics systems — characteristics, state of the art, and grand challenges
-
[188] Sitti, M., Microscale and nanoscale robotics systems — characteristics, state of the art, and grand challenges. IEEE Robot. Autom. Mag. 14 (2007), 53–60.
-
(2007)
IEEE Robot. Autom. Mag.
, vol.14
, pp. 53-60
-
-
Sitti, M.1
-
189
-
-
84898944072
-
Micro-scale mobile robotics
-
[189] Diller, E., Sitti, M., Micro-scale mobile robotics. Found. Trends Robot. 2 (2013), 143–259.
-
(2013)
Found. Trends Robot.
, vol.2
, pp. 143-259
-
-
Diller, E.1
Sitti, M.2
-
190
-
-
84961754987
-
Targeted drug delivery and imaging using mobile milli/microrobots: a promising future towards theranostic pharmaceutical design
-
[190] Singh, A.V., Sitti, M., Targeted drug delivery and imaging using mobile milli/microrobots: a promising future towards theranostic pharmaceutical design. Curr. Pharm. Des. 22 (2016), 1418–1428.
-
(2016)
Curr. Pharm. Des.
, vol.22
, pp. 1418-1428
-
-
Singh, A.V.1
Sitti, M.2
-
191
-
-
84877048690
-
Chemotactic steering of bacteria propelled microbeads
-
[191] Kim, D., Liu, A., Diller, E., Sitti, M., Chemotactic steering of bacteria propelled microbeads. Biomed. Microdevices 14 (2012), 1009–1017.
-
(2012)
Biomed. Microdevices
, vol.14
, pp. 1009-1017
-
-
Kim, D.1
Liu, A.2
Diller, E.3
Sitti, M.4
-
192
-
-
77949759705
-
Oral biofilm architecture on natural teeth
-
[192] Zijnge, V., van Leeuwen, M.B.M., Degener, J.E., Abbas, F., Thurnheer, T., Gmur, R., Harmsen, H.J.M., Oral biofilm architecture on natural teeth. PloS One, 5, 2010.
-
(2010)
PloS One
, vol.5
-
-
Zijnge, V.1
van Leeuwen, M.B.M.2
Degener, J.E.3
Abbas, F.4
Thurnheer, T.5
Gmur, R.6
Harmsen, H.J.M.7
-
193
-
-
0033694722
-
Dental plaque formation
-
[193] Rosan, B., Lamont, R.J., Dental plaque formation. Microbes Infect. 2 (2000), 1599–1607.
-
(2000)
Microbes Infect.
, vol.2
, pp. 1599-1607
-
-
Rosan, B.1
Lamont, R.J.2
-
194
-
-
73349137983
-
Biofilm on dental implants: a review of the literature
-
[194] Subramani, K., Jung, R.E., Molenberg, A., Hammerle, C.H.F., Biofilm on dental implants: a review of the literature. Int. J. Oral Maxillofac. Implants 24 (2009), 616–626.
-
(2009)
Int. J. Oral Maxillofac. Implants
, vol.24
, pp. 616-626
-
-
Subramani, K.1
Jung, R.E.2
Molenberg, A.3
Hammerle, C.H.F.4
-
195
-
-
33748291626
-
Effect of material characteristics and/or surface topography on biofilm development
-
[195] Teughels, W., Van Assche, N., Sliepen, I., Quirynen, M., Effect of material characteristics and/or surface topography on biofilm development. Clin. Oral Implants Res. 17 (2006), 68–81.
-
(2006)
Clin. Oral Implants Res.
, vol.17
, pp. 68-81
-
-
Teughels, W.1
Van Assche, N.2
Sliepen, I.3
Quirynen, M.4
-
196
-
-
77956938332
-
Biofilm formation and the food industry, a focus on the bacterial outer surface
-
[196] Van Houdt, R., Michiels, C., Biofilm formation and the food industry, a focus on the bacterial outer surface. J. Appl. Microbiol. 109 (2010), 1117–1131.
-
(2010)
J. Appl. Microbiol.
, vol.109
, pp. 1117-1131
-
-
Van Houdt, R.1
Michiels, C.2
-
197
-
-
80055041333
-
Bacterial biofilms: the powerhouse of a microbial fuel cell
-
[197] Franks, A.E., Malvankar, N., Nevin, K.P., Bacterial biofilms: the powerhouse of a microbial fuel cell. Biofuels 1 (2010), 589–604.
-
(2010)
Biofuels
, vol.1
, pp. 589-604
-
-
Franks, A.E.1
Malvankar, N.2
Nevin, K.P.3
-
198
-
-
78751634236
-
Engineering biofilm formation and dispersal
-
[198] Wood, T.K., Hong, S.H., Ma, Q., Engineering biofilm formation and dispersal. Trends Biotechnol. 29 (2011), 87–94.
-
(2011)
Trends Biotechnol.
, vol.29
, pp. 87-94
-
-
Wood, T.K.1
Hong, S.H.2
Ma, Q.3
-
199
-
-
0347324930
-
Attachment of marine- and fresh-water bacteria to solid surfaces
-
[199] Meadows, P.S., Attachment of marine- and fresh-water bacteria to solid surfaces. Nature, 207, 1965, 1108.
-
(1965)
Nature
, vol.207
, pp. 1108
-
-
Meadows, P.S.1
-
200
-
-
0032703889
-
Patterning proteins and cells using soft lithography
-
[200] Kane, R.S., Takayama, S., Ostuni, E., Ingber, D.E., Whitesides, G.M., Patterning proteins and cells using soft lithography. Biomaterials 20 (1999), 2363–2376.
-
(1999)
Biomaterials
, vol.20
, pp. 2363-2376
-
-
Kane, R.S.1
Takayama, S.2
Ostuni, E.3
Ingber, D.E.4
Whitesides, G.M.5
-
201
-
-
46849086549
-
Substrata mechanical stiffness can regulate adhesion of viable bacteria
-
[201] Lichter, J.A., Thompson, M.T., Delgadillo, M., Nishikawa, T., Rubner, M.F., Van Vliet, K.J., Substrata mechanical stiffness can regulate adhesion of viable bacteria. Biomacromolecules 9 (2008), 1571–1578.
-
(2008)
Biomacromolecules
, vol.9
, pp. 1571-1578
-
-
Lichter, J.A.1
Thompson, M.T.2
Delgadillo, M.3
Nishikawa, T.4
Rubner, M.F.5
Van Vliet, K.J.6
-
202
-
-
0030794353
-
Determination of bacterial cell surface hydrophobicity of single cells in cultures and in wastewater in situ
-
[202] Zita, A., Hermansson, M., Determination of bacterial cell surface hydrophobicity of single cells in cultures and in wastewater in situ. FEMS Microbiol. Lett. 152 (1997), 299–306.
-
(1997)
FEMS Microbiol. Lett.
, vol.152
, pp. 299-306
-
-
Zita, A.1
Hermansson, M.2
-
203
-
-
33846245916
-
Bacterial flagella-based propulsion and on/off motion control of microscale objects
-
[203] Behkam, B., Sitti, M., Bacterial flagella-based propulsion and on/off motion control of microscale objects. Appl. Phys. Lett., 90, 2007.
-
(2007)
Appl. Phys. Lett.
, vol.90
-
-
Behkam, B.1
Sitti, M.2
-
204
-
-
84966349717
-
Bacteria-based Microrobot for Chemotaxis Delivery, Control, Automation and Systems (ICCAS), 2015 15th International Conference on
-
[204] Huh, K., Oh, D., Yoo, H.J., Song, B., Cho, D.-i.D., Seo, J.-M., Kim, S.J., Bacteria-based Microrobot for Chemotaxis Delivery, Control, Automation and Systems (ICCAS), 2015 15th International Conference on. 2015, 1848–1852.
-
(2015)
, pp. 1848-1852
-
-
Huh, K.1
Oh, D.2
Yoo, H.J.3
Song, B.4
Cho, D.-I.D.5
Seo, J.-M.6
Kim, S.J.7
-
205
-
-
84908408722
-
Biomanufacturing and self-propulsion dynamics of nanoscale bacteria-enabled autonomous delivery systems
-
[205] Traore, M.A., Damico, C.M., Behkam, B., Biomanufacturing and self-propulsion dynamics of nanoscale bacteria-enabled autonomous delivery systems. Appl. Phys. Lett., 105, 2014.
-
(2014)
Appl. Phys. Lett.
, vol.105
-
-
Traore, M.A.1
Damico, C.M.2
Behkam, B.3
-
206
-
-
84946109909
-
Active tumor-therapeutic liposomal bacteriobot combining a drug (paclitaxel)-encapsulated liposome with targeting bacteria (Salmonella typhimurium)
-
[206] Nguyen, V.D., Han, J.-W., Choi, Y.J., Cho, S., Zheng, S., Ko, S.Y., Park, J.-O., Park, S., Active tumor-therapeutic liposomal bacteriobot combining a drug (paclitaxel)-encapsulated liposome with targeting bacteria (Salmonella typhimurium). Sensors Actuators B Chem. 224 (2016), 217–224.
-
(2016)
Sensors Actuators B Chem.
, vol.224
, pp. 217-224
-
-
Nguyen, V.D.1
Han, J.-W.2
Choi, Y.J.3
Cho, S.4
Zheng, S.5
Ko, S.Y.6
Park, J.-O.7
Park, S.8
-
207
-
-
84901649873
-
Covalent binding of nanoliposomes to the surface of magnetotactic bacteria for the synthesis of self-propelled therapeutic agents
-
[207] Taherkhani, S., Mohammadi, M., Daoud, J., Martel, S., Tabrizian, M., Covalent binding of nanoliposomes to the surface of magnetotactic bacteria for the synthesis of self-propelled therapeutic agents. ACS Nano 8 (2014), 5049–5060.
-
(2014)
ACS Nano
, vol.8
, pp. 5049-5060
-
-
Taherkhani, S.1
Mohammadi, M.2
Daoud, J.3
Martel, S.4
Tabrizian, M.5
-
208
-
-
77953800514
-
Motility enhancement of bacteria actuated microstructures using selective bacteria adhesion
-
[208] Park, S.J., Bae, H., Kim, J., Lim, B., Park, J., Park, S., Motility enhancement of bacteria actuated microstructures using selective bacteria adhesion. Lab Chip 10 (2010), 1706–1711.
-
(2010)
Lab Chip
, vol.10
, pp. 1706-1711
-
-
Park, S.J.1
Bae, H.2
Kim, J.3
Lim, B.4
Park, J.5
Park, S.6
-
209
-
-
84877049102
-
Development of bacteria-based microrobot using biocompatible poly(ethylene glycol)
-
[209] Cho, S., Park, S., Ko, S., Park, J.-O., Park, S., Development of bacteria-based microrobot using biocompatible poly(ethylene glycol). Biomed. Microdevices 14 (2012), 1019–1025.
-
(2012)
Biomed. Microdevices
, vol.14
, pp. 1019-1025
-
-
Cho, S.1
Park, S.2
Ko, S.3
Park, J.-O.4
Park, S.5
-
210
-
-
57349108681
-
Effect of quantity and configuration of attached bacteria on bacterial propulsion of microbeads
-
[210] Behkam, B., Sitti, M., Effect of quantity and configuration of attached bacteria on bacterial propulsion of microbeads. Appl. Phys. Lett., 93, 2008, 223901.
-
(2008)
Appl. Phys. Lett.
, vol.93
, pp. 223901
-
-
Behkam, B.1
Sitti, M.2
-
211
-
-
84971413321
-
Patterned and specific attachment of bacteria on biohybrid bacteria-driven microswimmers
-
(in press)
-
[211] Singh, A.V., Sitti, M., Patterned and specific attachment of bacteria on biohybrid bacteria-driven microswimmers. Adv. Healthcare Mater., 2016, 10.1002/adhm.201600155 (in press).
-
(2016)
Adv. Healthcare Mater.
-
-
Singh, A.V.1
Sitti, M.2
-
212
-
-
84932193213
-
A hybrid actuated microrobot using an electromagnetic field and flagellated bacteria for tumor-targeting therapy
-
[212] Li, D., Choi, H., Cho, S., Jeong, S., Jin, Z., Lee, C., Ko, S.Y., Park, J.-O., Park, S., A hybrid actuated microrobot using an electromagnetic field and flagellated bacteria for tumor-targeting therapy. Biotechnol. Bioeng. 112 (2015), 1623–1631.
-
(2015)
Biotechnol. Bioeng.
, vol.112
, pp. 1623-1631
-
-
Li, D.1
Choi, H.2
Cho, S.3
Jeong, S.4
Jin, Z.5
Lee, C.6
Ko, S.Y.7
Park, J.-O.8
Park, S.9
-
213
-
-
84923299174
-
Optical assembly of bio-hybrid micro-robots
-
[213] Barroso, Á., Landwerth, S., Woerdemann, M., Alpmann, C., Buscher, T., Becker, M., Studer, A., Denz, C., Optical assembly of bio-hybrid micro-robots. Biomed. Microdevices 17 (2015), 1–8.
-
(2015)
Biomed. Microdevices
, vol.17
, pp. 1-8
-
-
Barroso, Á.1
Landwerth, S.2
Woerdemann, M.3
Alpmann, C.4
Buscher, T.5
Becker, M.6
Studer, A.7
Denz, C.8
-
214
-
-
24744433512
-
Microoxen: microorganisms to move microscale loads
-
[214] Weibel, D.B., Garstecki, P., Ryan, D., DiLuzio, W.R., Mayer, M., Seto, J.E., Whitesides, G.M., Microoxen: microorganisms to move microscale loads. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 11963–11967.
-
(2005)
Proc. Natl. Acad. Sci. U. S. A.
, vol.102
, pp. 11963-11967
-
-
Weibel, D.B.1
Garstecki, P.2
Ryan, D.3
DiLuzio, W.R.4
Mayer, M.5
Seto, J.E.6
Whitesides, G.M.7
-
215
-
-
34447118226
-
Bacteria-mediated delivery of nanoparticles and cargo into cells
-
[215] Akin, D., Sturgis, J., Ragheb, K., Sherman, D., Burkholder, K., Robinson, J.P., Bhunia, A.K., Mohammed, S., Bashir, R., Bacteria-mediated delivery of nanoparticles and cargo into cells. Nat. Nanotechnol. 2 (2007), 441–449.
-
(2007)
Nat. Nanotechnol.
, vol.2
, pp. 441-449
-
-
Akin, D.1
Sturgis, J.2
Ragheb, K.3
Sherman, D.4
Burkholder, K.5
Robinson, J.P.6
Bhunia, A.K.7
Mohammed, S.8
Bashir, R.9
-
216
-
-
79952204827
-
Enabling cargo-carrying bacteria via surface attachment and triggered release
-
[216] Fernandes, R., Zuniga, M., Sassine, F.R., Karakoy, M., Gracias, D.H., Enabling cargo-carrying bacteria via surface attachment and triggered release. Small 7 (2011), 588–592.
-
(2011)
Small
, vol.7
, pp. 588-592
-
-
Fernandes, R.1
Zuniga, M.2
Sassine, F.R.3
Karakoy, M.4
Gracias, D.H.5
-
217
-
-
84900470584
-
Assessment of PEG on polymeric particles surface, a key step in drug carrier translation
-
[217] Rabanel, J.M., Hildgen, P., Banquy, X., Assessment of PEG on polymeric particles surface, a key step in drug carrier translation. J. Control. Release 185 (2014), 71–87.
-
(2014)
J. Control. Release
, vol.185
, pp. 71-87
-
-
Rabanel, J.M.1
Hildgen, P.2
Banquy, X.3
-
218
-
-
84904858693
-
PEG - A versatile conjugating ligand for drugs and drug delivery systems
-
[218] Kolate, A., Baradia, D., Patil, S., Vhora, I., Kore, G., Misra, A., PEG - A versatile conjugating ligand for drugs and drug delivery systems. J. Control. Release 192 (2014), 67–81.
-
(2014)
J. Control. Release
, vol.192
, pp. 67-81
-
-
Kolate, A.1
Baradia, D.2
Patil, S.3
Vhora, I.4
Kore, G.5
Misra, A.6
-
219
-
-
84876468104
-
Propulsion of liposomes using bacterial motors
-
[219] Zhang, Z., Li, Z., Yu, W., Li, K., Xie, Z., Shi, Z., Propulsion of liposomes using bacterial motors. Nanotechnology, 24, 2013, 185103.
-
(2013)
Nanotechnology
, vol.24
, pp. 185103
-
-
Zhang, Z.1
Li, Z.2
Yu, W.3
Li, K.4
Xie, Z.5
Shi, Z.6
-
220
-
-
84877059448
-
Construction and evaluation of bacteria-driven liposome
-
[220] Kojima, M., Zhang, Z., Nakajima, M., Ooe, K., Fukuda, T., Construction and evaluation of bacteria-driven liposome. Sensors Actuators B Chem. 183 (2013), 395–400.
-
(2013)
Sensors Actuators B Chem.
, vol.183
, pp. 395-400
-
-
Kojima, M.1
Zhang, Z.2
Nakajima, M.3
Ooe, K.4
Fukuda, T.5
-
221
-
-
85027935646
-
Swimming characterization of Serratia marcescens for bio-hybrid micro-robotics
-
[221] Edwards, M.R., Carlsen, R.W., Zhuang, J., Sitti, M., Swimming characterization of Serratia marcescens for bio-hybrid micro-robotics. J. Micro-Bio Robot. 9 (2014), 47–60.
-
(2014)
J. Micro-Bio Robot.
, vol.9
, pp. 47-60
-
-
Edwards, M.R.1
Carlsen, R.W.2
Zhuang, J.3
Sitti, M.4
-
223
-
-
34248402413
-
Shape effects of filaments versus spherical particles in flow and drug delivery
-
[223] Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., Discher, D.E., Shape effects of filaments versus spherical particles in flow and drug delivery. Nat. Nanotechnol. 2 (2007), 249–255.
-
(2007)
Nat. Nanotechnol.
, vol.2
, pp. 249-255
-
-
Geng, Y.1
Dalhaimer, P.2
Cai, S.3
Tsai, R.4
Tewari, M.5
Minko, T.6
Discher, D.E.7
-
224
-
-
84923923594
-
Nano and micro architectures for self-propelled motors
-
[224] Jemish, P., Xing, M., Jaideep, K., Juliane, S., Morgan, M.S., Carolina, T.-P., Lluís, S., Samuel, S., Nano and micro architectures for self-propelled motors. Sci. Technol. Adv. Mater., 16, 2015, 014802.
-
(2015)
Sci. Technol. Adv. Mater.
, vol.16
, pp. 014802
-
-
Jemish, P.1
Xing, M.2
Jaideep, K.3
Juliane, S.4
Morgan, M.S.5
Carolina, T.-P.6
Lluís, S.7
Samuel, S.8
-
225
-
-
84919762629
-
Motility control of bacteria-actuated biodegradable polymeric microstructures by selective adhesion methods
-
[225] Yoo, H.J., Lee, S., Cho, D.-i.D., Motility control of bacteria-actuated biodegradable polymeric microstructures by selective adhesion methods. Micromachines 5 (2014), 1287–1295.
-
(2014)
Micromachines
, vol.5
, pp. 1287-1295
-
-
Yoo, H.J.1
Lee, S.2
Cho, D.-I.D.3
-
226
-
-
84908447541
-
Directed transport of bacteria-based drug delivery vehicles: bacterial chemotaxis dominates particle shape
-
[226] Sahari, A., Traore, M.A., Scharf, B.E., Behkam, B., Directed transport of bacteria-based drug delivery vehicles: bacterial chemotaxis dominates particle shape. Biomed. Microdevices 16 (2014), 717–725.
-
(2014)
Biomed. Microdevices
, vol.16
, pp. 717-725
-
-
Sahari, A.1
Traore, M.A.2
Scharf, B.E.3
Behkam, B.4
-
227
-
-
84877075605
-
Effect of body shape on the motile behavior of bacteria-powered swimming microrobots (BacteriaBots)
-
[227] Sahari, A., Headen, D., Behkam, B., Effect of body shape on the motile behavior of bacteria-powered swimming microrobots (BacteriaBots). Biomed. Microdevices 14 (2012), 999–1007.
-
(2012)
Biomed. Microdevices
, vol.14
, pp. 999-1007
-
-
Sahari, A.1
Headen, D.2
Behkam, B.3
-
228
-
-
84902270958
-
A self-swimming microbial robot using microfabricated nanofibrous hydrogel
-
[228] Higashi, K., Miki, N., A self-swimming microbial robot using microfabricated nanofibrous hydrogel. Sensors Actuators B Chem. 202 (2014), 301–306.
-
(2014)
Sensors Actuators B Chem.
, vol.202
, pp. 301-306
-
-
Higashi, K.1
Miki, N.2
-
229
-
-
84956736491
-
Preparation of Engineered Salmonella Typhimurium-Driven Hyaluronic-Acid-Based Microbeads with Both Chemotactic and Biological Targeting Towards Breast Cancer Cells for Enhanced Anticancer Therapy
-
[229] Uthaman, S., Zheng, S., Han, J., Choi, Y.J., Cho, S., Nguyen, V.D., Park, J.O., Park, S.H., Min, J.J., Park, S., Park, I.K., Preparation of Engineered Salmonella Typhimurium-Driven Hyaluronic-Acid-Based Microbeads with Both Chemotactic and Biological Targeting Towards Breast Cancer Cells for Enhanced Anticancer Therapy. Adv Healthc Mater. 21;5:2 (2016), 288–295.
-
(2016)
Adv Healthc Mater.
, vol.21;5
, Issue.2
, pp. 288-295
-
-
Uthaman, S.1
Zheng, S.2
Han, J.3
Choi, Y.J.4
Cho, S.5
Nguyen, V.D.6
Park, J.O.7
Park, S.H.8
Min, J.J.9
Park, S.10
Park, I.K.11
-
230
-
-
84924041692
-
Effect of chitosan coating on a bacteria-based alginate microrobot
-
[230] Park, S.J., Lee, Y.K., Cho, S., Uthaman, S., Park, I.K., Min, J.J., Ko, S.Y., Park, J.O., Park, S., Effect of chitosan coating on a bacteria-based alginate microrobot. Biotechnol. Bioeng. 112 (2015), 769–776.
-
(2015)
Biotechnol. Bioeng.
, vol.112
, pp. 769-776
-
-
Park, S.J.1
Lee, Y.K.2
Cho, S.3
Uthaman, S.4
Park, I.K.5
Min, J.J.6
Ko, S.Y.7
Park, J.O.8
Park, S.9
-
231
-
-
84876385372
-
Near and far-wall effects on the three-dimensional motion of bacteria-driven microbeads
-
[231] Edwards, M.R., Wright Carlsen, R., Sitti, M., Near and far-wall effects on the three-dimensional motion of bacteria-driven microbeads. Appl. Phys. Lett., 102, 2013, 143701.
-
(2013)
Appl. Phys. Lett.
, vol.102
, pp. 143701
-
-
Edwards, M.R.1
Wright Carlsen, R.2
Sitti, M.3
-
232
-
-
79959383468
-
Modeling of stochastic motion of bacteria propelled spherical microbeads
-
[232] Arabagi, V., Behkam, B., Cheung, E., Sitti, M., Modeling of stochastic motion of bacteria propelled spherical microbeads. J. Appl. Phys., 109, 2011, 114702.
-
(2011)
J. Appl. Phys.
, vol.109
, pp. 114702
-
-
Arabagi, V.1
Behkam, B.2
Cheung, E.3
Sitti, M.4
-
233
-
-
84455192612
-
Chemotactic behavior and dynamics of bacteria propelled microbeads
-
[233] Kim, D., Liu, A., Stitti, M., Chemotactic behavior and dynamics of bacteria propelled microbeads. 2011 IEEE/RSJ International Conference on Intelligent Robots and Systems, 2011, 1674–1679.
-
(2011)
2011 IEEE/RSJ International Conference on Intelligent Robots and Systems
, pp. 1674-1679
-
-
Kim, D.1
Liu, A.2
Stitti, M.3
-
234
-
-
84900418016
-
Analytical modeling and experimental characterization of chemotaxis in Serratia marcescens
-
[234] Zhuang, J., Wei, G., Wright Carlsen, R., Edwards, M.R., Marculescu, R., Bogdan, P., Sitti, M., Analytical modeling and experimental characterization of chemotaxis in Serratia marcescens. Phys. Rev. E, 89, 2014, 052704.
-
(2014)
Phys. Rev. E
, vol.89
, pp. 052704
-
-
Zhuang, J.1
Wei, G.2
Wright Carlsen, R.3
Edwards, M.R.4
Marculescu, R.5
Bogdan, P.6
Sitti, M.7
-
235
-
-
84861836686
-
Responding to chemical gradients: bacterial chemotaxis
-
[235] Sourjik, V., Wingreen, N.S., Responding to chemical gradients: bacterial chemotaxis. Curr. Opin. Cell Biol. 24 (2012), 262–268.
-
(2012)
Curr. Opin. Cell Biol.
, vol.24
, pp. 262-268
-
-
Sourjik, V.1
Wingreen, N.S.2
-
236
-
-
84974802738
-
Bacteria-mediated hypoxia-specific delivery of nanoparticles for tumors imaging and therapy
-
[236] Luo, C.-H., Huang, C.-T., Su, C.-H., Yeh, C.-S., Bacteria-mediated hypoxia-specific delivery of nanoparticles for tumors imaging and therapy. Nano Lett. 16 (2016), 3493–3499.
-
(2016)
Nano Lett.
, vol.16
, pp. 3493-3499
-
-
Luo, C.-H.1
Huang, C.-T.2
Su, C.-H.3
Yeh, C.-S.4
-
237
-
-
84984685601
-
Chemotaxis of bio-hybrid multiple bacteria-driven microswimmers
-
[237] Zhuang, J., Sitti, M., Chemotaxis of bio-hybrid multiple bacteria-driven microswimmers. Sci. Report., 6, 2016, 32135.
-
(2016)
Sci. Report.
, vol.6
, pp. 32135
-
-
Zhuang, J.1
Sitti, M.2
-
238
-
-
84888035739
-
Motility analysis of bacteria-based microrobot (bacteriobot) using chemical gradient microchamber
-
[238] Park, D., Park, S.J., Cho, S., Lee, Y., Lee, Y.K., Min, J.J., Park, B.J., Ko, S.Y., Park, J.O., Park, S., Motility analysis of bacteria-based microrobot (bacteriobot) using chemical gradient microchamber. Biotechnol. Bioeng. 111 (2014), 134–143.
-
(2014)
Biotechnol. Bioeng.
, vol.111
, pp. 134-143
-
-
Park, D.1
Park, S.J.2
Cho, S.3
Lee, Y.4
Lee, Y.K.5
Min, J.J.6
Park, B.J.7
Ko, S.Y.8
Park, J.O.9
Park, S.10
-
239
-
-
84555195646
-
Computational and experimental study of chemotaxis of an ensemble of bacteria attached to a microbead
-
[239] Traore, M.A., Sahari, A., Behkam, B., Computational and experimental study of chemotaxis of an ensemble of bacteria attached to a microbead. Phys. Rev. E, 84, 2011.
-
(2011)
Phys. Rev. E
, vol.84
-
-
Traore, M.A.1
Sahari, A.2
Behkam, B.3
-
240
-
-
84962046006
-
Bacterial chemotaxis-enabled autonomous sorting of nanoparticles of comparable sizes
-
[240] Suh, S., Traore, M.A., Behkam, B., Bacterial chemotaxis-enabled autonomous sorting of nanoparticles of comparable sizes. Lab Chip 16 (2016), 1254–1260.
-
(2016)
Lab Chip
, vol.16
, pp. 1254-1260
-
-
Suh, S.1
Traore, M.A.2
Behkam, B.3
-
241
-
-
84889045375
-
New paradigm for tumor theranostic methodology using bacteria-based microrobot
-
[241] Park, S.J., Park, S.H., Cho, S., Kim, D.M., Lee, Y., Ko, S.Y., Hong, Y., Choy, H.E., Min, J.J., Park, J.O., Park, S., New paradigm for tumor theranostic methodology using bacteria-based microrobot. Sci. Rep., 3, 2013.
-
(2013)
Sci. Rep.
, vol.3
-
-
Park, S.J.1
Park, S.H.2
Cho, S.3
Kim, D.M.4
Lee, Y.5
Ko, S.Y.6
Hong, Y.7
Choy, H.E.8
Min, J.J.9
Park, J.O.10
Park, S.11
-
242
-
-
84918800963
-
Toward development of an autonomous network of bacteria-based delivery systems (BacteriaBots): spatiotemporally high-throughput characterization of bacterial quorum-sensing response
-
[242] Sahari, A., Traore, M.A., Stevens, A.M., Scharf, B.E., Behkam, B., Toward development of an autonomous network of bacteria-based delivery systems (BacteriaBots): spatiotemporally high-throughput characterization of bacterial quorum-sensing response. Anal. Chem. 86 (2014), 11489–11493.
-
(2014)
Anal. Chem.
, vol.86
, pp. 11489-11493
-
-
Sahari, A.1
Traore, M.A.2
Stevens, A.M.3
Scharf, B.E.4
Behkam, B.5
-
243
-
-
84903719453
-
Influence of magnetic fields on magneto-aerotaxis
-
e101150
-
[243] Bennet, M., McCarthy, A., Fix, D., Edwards, M.R., Repp, F., Vach, P., Dunlop, J.W.C., Sitti, M., Buller, G.S., Klumpp, S., Faivre, D., Influence of magnetic fields on magneto-aerotaxis. PLoS One, 9, 2014, e101150.
-
(2014)
PLoS One
, vol.9
-
-
Bennet, M.1
McCarthy, A.2
Fix, D.3
Edwards, M.R.4
Repp, F.5
Vach, P.6
Dunlop, J.W.C.7
Sitti, M.8
Buller, G.S.9
Klumpp, S.10
Faivre, D.11
-
244
-
-
0036253177
-
Route of administration differentially affects fevers induced by Gram-negative and Gram-positive pyrogens in rabbits
-
[244] Cartmell, T., Mitchell, D., Lamond, F.J.D., Laburn, H.P., Route of administration differentially affects fevers induced by Gram-negative and Gram-positive pyrogens in rabbits. Exp. Physiol. 87 (2002), 391–399.
-
(2002)
Exp. Physiol.
, vol.87
, pp. 391-399
-
-
Cartmell, T.1
Mitchell, D.2
Lamond, F.J.D.3
Laburn, H.P.4
-
245
-
-
34547812592
-
Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria
-
[245] Cortes-Perez, N.G., Lefevre, F., Corthier, G., Adel-Patient, K., Langella, P., Bermudez-Humaran, L.G., Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria. Vaccine 25 (2007), 6581–6588.
-
(2007)
Vaccine
, vol.25
, pp. 6581-6588
-
-
Cortes-Perez, N.G.1
Lefevre, F.2
Corthier, G.3
Adel-Patient, K.4
Langella, P.5
Bermudez-Humaran, L.G.6
-
246
-
-
79955046293
-
Influence of infection route and virulence factors on colonization of solid tumors by Salmonella enterica serovar typhimurium
-
[246] Crull, K., Bumann, D., Weiss, S., Influence of infection route and virulence factors on colonization of solid tumors by Salmonella enterica serovar typhimurium. FEMS Immunol. Med. Microbiol. 62 (2011), 75–83.
-
(2011)
FEMS Immunol. Med. Microbiol.
, vol.62
, pp. 75-83
-
-
Crull, K.1
Bumann, D.2
Weiss, S.3
-
247
-
-
84907415255
-
Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses
-
[247] Roberts, N.J., Zhang, L.P., Janku, F., Collins, A., Bai, R.Y., Staedtke, V., Rusk, A.W., Tung, D., Miller, M., Roix, J., Khanna, K.V., Murthy, R., Benjamin, R.S., Helgason, T., Szvalb, A.D., Bird, J.E., Roy-Chowdhuri, S., Zhang, H.H., Qiao, Y., Karim, B., McDaniel, J., Elpiner, A., Sahora, A., Lachowicz, J., Phillips, B., Turner, A., Klein, M.K., Post, G., Diaz, L.A., Riggins, G.J., Papadopoulos, N., Kinzler, K.W., Vogelstein, B., Bettegowda, C., Huso, D.L., Varterasian, M., Saha, S., Zhou, S.B., Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses. Sci. Transl. Med., 6, 2014.
-
(2014)
Sci. Transl. Med.
, vol.6
-
-
Roberts, N.J.1
Zhang, L.P.2
Janku, F.3
Collins, A.4
Bai, R.Y.5
Staedtke, V.6
Rusk, A.W.7
Tung, D.8
Miller, M.9
Roix, J.10
Khanna, K.V.11
Murthy, R.12
Benjamin, R.S.13
Helgason, T.14
Szvalb, A.D.15
Bird, J.E.16
Roy-Chowdhuri, S.17
Zhang, H.H.18
Qiao, Y.19
Karim, B.20
McDaniel, J.21
Elpiner, A.22
Sahora, A.23
Lachowicz, J.24
Phillips, B.25
Turner, A.26
Klein, M.K.27
Post, G.28
Diaz, L.A.29
Riggins, G.J.30
Papadopoulos, N.31
Kinzler, K.W.32
Vogelstein, B.33
Bettegowda, C.34
Huso, D.L.35
Varterasian, M.36
Saha, S.37
Zhou, S.B.38
more..
-
248
-
-
14144251067
-
Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium
-
[248] Zhao, M., Yang, M., Li, X.M., Jiang, P., Baranov, E., Li, S.K., Xu, M.X., Penman, S., Hoffman, R.M., Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 755–760.
-
(2005)
Proc. Natl. Acad. Sci. U. S. A.
, vol.102
, pp. 755-760
-
-
Zhao, M.1
Yang, M.2
Li, X.M.3
Jiang, P.4
Baranov, E.5
Li, S.K.6
Xu, M.X.7
Penman, S.8
Hoffman, R.M.9
-
249
-
-
84863487143
-
Neurological diseases in relation to the blood–brain barrier
-
[249] Rosenberg, G.A., Neurological diseases in relation to the blood–brain barrier. J. Cereb. Blood Flow Metab. 32 (2012), 1139–1151.
-
(2012)
J. Cereb. Blood Flow Metab.
, vol.32
, pp. 1139-1151
-
-
Rosenberg, G.A.1
-
250
-
-
84858060614
-
Defense at the border: the blood–brain barrier versus bacterial foreigners
-
[250] van Sorge, N.M., Doran, K.S., Defense at the border: the blood–brain barrier versus bacterial foreigners. Future Microbiol 7 (2012), 383–394.
-
(2012)
Future Microbiol
, vol.7
, pp. 383-394
-
-
van Sorge, N.M.1
Doran, K.S.2
-
251
-
-
84925865128
-
Intratumoral Clostridium novyi as a potential treatment for solid necrotic brain tumors
-
[251] Zwagerman, N.T., Friedlander, R.M., Monaco, E.A., Intratumoral Clostridium novyi as a potential treatment for solid necrotic brain tumors. Neurosurgery 75 (2014), N17–N18.
-
(2014)
Neurosurgery
, vol.75
, pp. N17-N18
-
-
Zwagerman, N.T.1
Friedlander, R.M.2
Monaco, E.A.3
-
252
-
-
84859709092
-
Microfabrication technologies for oral drug delivery
-
[252] Sant, S., Tao, S.L., Fisher, O.Z., Xu, Q.B., Peppas, N.A., Khademhosseini, A., Microfabrication technologies for oral drug delivery. Adv. Drug Deliv. Rev. 64 (2012), 496–507.
-
(2012)
Adv. Drug Deliv. Rev.
, vol.64
, pp. 496-507
-
-
Sant, S.1
Tao, S.L.2
Fisher, O.Z.3
Xu, Q.B.4
Peppas, N.A.5
Khademhosseini, A.6
-
253
-
-
0034176470
-
Recent technological advances in oral drug delivery — a review
-
[253] Sastry, S.V., Nyshadham, J.R., Fix, J.A., Recent technological advances in oral drug delivery — a review. Pharm. Sci. Technol. Today 3 (2000), 138–145.
-
(2000)
Pharm. Sci. Technol. Today
, vol.3
, pp. 138-145
-
-
Sastry, S.V.1
Nyshadham, J.R.2
Fix, J.A.3
-
254
-
-
84861990084
-
Crossing the barrier: targeting epithelial receptors for enhanced oral vaccine delivery
-
[254] Devriendt, B., De Geest, B.G., Goddeeris, B.M., Cox, E., Crossing the barrier: targeting epithelial receptors for enhanced oral vaccine delivery. J. Control. Release 160 (2012), 431–439.
-
(2012)
J. Control. Release
, vol.160
, pp. 431-439
-
-
Devriendt, B.1
De Geest, B.G.2
Goddeeris, B.M.3
Cox, E.4
-
255
-
-
84871609642
-
Vaccine delivery carriers: insights and future perspectives
-
[255] Correia-Pinto, J.F., Csaba, N., Alonso, M.J., Vaccine delivery carriers: insights and future perspectives. Int. J. Pharm. 440 (2013), 27–38.
-
(2013)
Int. J. Pharm.
, vol.440
, pp. 27-38
-
-
Correia-Pinto, J.F.1
Csaba, N.2
Alonso, M.J.3
-
256
-
-
84950000531
-
What's next for gastrointestinal disorders: no needles?
-
[256] Urbanska, A.M., Karagiannis, E.D., Au, A.S., Dai, S.Y., Mozafari, M., Prakash, S., What's next for gastrointestinal disorders: no needles?. J. Control. Release 221 (2016), 48–61.
-
(2016)
J. Control. Release
, vol.221
, pp. 48-61
-
-
Urbanska, A.M.1
Karagiannis, E.D.2
Au, A.S.3
Dai, S.Y.4
Mozafari, M.5
Prakash, S.6
-
257
-
-
84869054314
-
Lactic acid bacteria as oral delivery systems for biomolecules
-
[257] Berlec, A., Ravnikar, M., Strukelj, B., Lactic acid bacteria as oral delivery systems for biomolecules. Pharmazie 67 (2012), 891–898.
-
(2012)
Pharmazie
, vol.67
, pp. 891-898
-
-
Berlec, A.1
Ravnikar, M.2
Strukelj, B.3
-
258
-
-
84890608517
-
Oral delivery of IL-27 recombinant bacteria attenuates immune colitis in mice
-
(210-+)
-
[258] Hanson, M.L., Hixon, J.A., Li, W.Q., Felber, B.K., Anver, M.R., Stewart, C.A., Janelsins, B.M., Datta, S.K., Shen, W., McLean, M.H., Durum, S.K., Oral delivery of IL-27 recombinant bacteria attenuates immune colitis in mice. Gastroenterology, 146, 2014 (210-+).
-
(2014)
Gastroenterology
, vol.146
-
-
Hanson, M.L.1
Hixon, J.A.2
Li, W.Q.3
Felber, B.K.4
Anver, M.R.5
Stewart, C.A.6
Janelsins, B.M.7
Datta, S.K.8
Shen, W.9
McLean, M.H.10
Durum, S.K.11
-
259
-
-
84905003513
-
Oral delivery of glutamic acid decarboxylase (GAD)-65 and IL10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice
-
[259] Robert, S., Gysemans, C., Takiishi, T., Korf, H., Spagnuolo, I., Sebastiani, G., Van Huynegem, K., Steidler, L., Caluwaerts, S., Demetter, P., Wasserfall, C.H., Atkinson, M.A., Dotta, F., Rottiers, P., Van Belle, T.L., Mathieu, C., Oral delivery of glutamic acid decarboxylase (GAD)-65 and IL10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice. Diabetes 63 (2014), 2876–2887.
-
(2014)
Diabetes
, vol.63
, pp. 2876-2887
-
-
Robert, S.1
Gysemans, C.2
Takiishi, T.3
Korf, H.4
Spagnuolo, I.5
Sebastiani, G.6
Van Huynegem, K.7
Steidler, L.8
Caluwaerts, S.9
Demetter, P.10
Wasserfall, C.H.11
Atkinson, M.A.12
Dotta, F.13
Rottiers, P.14
Van Belle, T.L.15
Mathieu, C.16
-
260
-
-
84924872871
-
The recombinant Lactococcus lactis oral vaccine induces protection against C. difficile spore challenge in a mouse model
-
[260] Guo, S.G., Yan, W.W., McDonough, S.P., Lin, N.F., Wu, K.J., He, H.X., Xiang, H., Yang, M.S., Moreira, M.A.S., Chang, Y.F., The recombinant Lactococcus lactis oral vaccine induces protection against C. difficile spore challenge in a mouse model. Vaccine 33 (2015), 1586–1595.
-
(2015)
Vaccine
, vol.33
, pp. 1586-1595
-
-
Guo, S.G.1
Yan, W.W.2
McDonough, S.P.3
Lin, N.F.4
Wu, K.J.5
He, H.X.6
Xiang, H.7
Yang, M.S.8
Moreira, M.A.S.9
Chang, Y.F.10
-
261
-
-
84902011138
-
Oral immunization with Lactococcus lactis-expressing EspB induces protective immune responses against Escherichia coli O157:H7 in a murine model of colonization
-
[261] Ahmed, B., Loos, M., Vanrompay, D., Cox, E., Oral immunization with Lactococcus lactis-expressing EspB induces protective immune responses against Escherichia coli O157:H7 in a murine model of colonization. Vaccine 32 (2014), 3909–3916.
-
(2014)
Vaccine
, vol.32
, pp. 3909-3916
-
-
Ahmed, B.1
Loos, M.2
Vanrompay, D.3
Cox, E.4
-
262
-
-
84949816734
-
Oral Bifidobacterium longum expressing alpha-melanocyte-stimulating hormone to fight experimental colitis
-
[262] Wei, P., Yang, Y., Liu, Z., Huang, J., Gong, Y., Sun, H., Oral Bifidobacterium longum expressing alpha-melanocyte-stimulating hormone to fight experimental colitis. Drug Deliv. 23:6 (2016), 2058–2064.
-
(2016)
Drug Deliv.
, vol.23
, Issue.6
, pp. 2058-2064
-
-
Wei, P.1
Yang, Y.2
Liu, Z.3
Huang, J.4
Gong, Y.5
Sun, H.6
-
263
-
-
84899994046
-
Oral administration of genetically modified Bifidobacterium displaying HCV-NS3 multi-epitope fusion protein could induce an HCV-NS3-specific systemic immune response in mice
-
[263] Takei, S., Omoto, C., Kitagawa, K., Morishita, N., Katayama, T., Shigemura, K., Fujisawa, M., Kawabata, M., Hotta, H., Shirakawa, T., Oral administration of genetically modified Bifidobacterium displaying HCV-NS3 multi-epitope fusion protein could induce an HCV-NS3-specific systemic immune response in mice. Vaccine 32 (2014), 3066–3074.
-
(2014)
Vaccine
, vol.32
, pp. 3066-3074
-
-
Takei, S.1
Omoto, C.2
Kitagawa, K.3
Morishita, N.4
Katayama, T.5
Shigemura, K.6
Fujisawa, M.7
Kawabata, M.8
Hotta, H.9
Shirakawa, T.10
-
264
-
-
84856113930
-
Bifidobacterium as an oral delivery carrier of interleukin-12 for the treatment of Coxsackie virus B3-induced myocarditis in the Balb/c mice
-
[264] Yu, Z.J., Huang, Z., Sao, C.W., Huang, Y.J., Zhang, F., Yang, J., Lian, J., Zeng, Z.M., Luo, W.S., Zeng, W.S., Deng, Q.W., Bifidobacterium as an oral delivery carrier of interleukin-12 for the treatment of Coxsackie virus B3-induced myocarditis in the Balb/c mice. Int. Immunopharmacol. 12 (2012), 125–130.
-
(2012)
Int. Immunopharmacol.
, vol.12
, pp. 125-130
-
-
Yu, Z.J.1
Huang, Z.2
Sao, C.W.3
Huang, Y.J.4
Zhang, F.5
Yang, J.6
Lian, J.7
Zeng, Z.M.8
Luo, W.S.9
Zeng, W.S.10
Deng, Q.W.11
-
265
-
-
58549115886
-
Oral delivery of DNA vaccine encoding VP28 against white spot syndrome virus in crayfish by attenuated Salmonella typhimurium
-
[265] Ning, J.F., Zhu, W., Xu, J.P., Zheng, C.Y., Meng, X.L., Oral delivery of DNA vaccine encoding VP28 against white spot syndrome virus in crayfish by attenuated Salmonella typhimurium. Vaccine 27 (2009), 1127–1135.
-
(2009)
Vaccine
, vol.27
, pp. 1127-1135
-
-
Ning, J.F.1
Zhu, W.2
Xu, J.P.3
Zheng, C.Y.4
Meng, X.L.5
-
266
-
-
70649083893
-
Oral delivery of tumor-targeting Salmonella exhibits promising therapeutic efficacy and low toxicity
-
[266] Chen, G., Wei, D.P., Jia, L.J., Tang, B., Shu, L., Zhang, K., Xu, Y., Gao, J., Huang, X.F., Jiang, W.H., Hu, Q.G., Huang, Y., Wu, Q., Sun, Z.H., Zhang, J.F., Hua, Z.C., Oral delivery of tumor-targeting Salmonella exhibits promising therapeutic efficacy and low toxicity. Cancer Sci. 100 (2009), 2437–2443.
-
(2009)
Cancer Sci.
, vol.100
, pp. 2437-2443
-
-
Chen, G.1
Wei, D.P.2
Jia, L.J.3
Tang, B.4
Shu, L.5
Zhang, K.6
Xu, Y.7
Gao, J.8
Huang, X.F.9
Jiang, W.H.10
Hu, Q.G.11
Huang, Y.12
Wu, Q.13
Sun, Z.H.14
Zhang, J.F.15
Hua, Z.C.16
-
267
-
-
84994905179
-
Development of a therapeutic RNAi delivery system using nonpathogenic bacteria expressing inv and hly: transkingdom RNA interference (tkRNAi)
-
[267] Grillot-Courvalin, C., Goussard, S., Courvalin, P., Silva, A., Bodyak, N., Vaze, M., Sauer, N., Laroux, F.S., Harborth, J., Xiang, S., Li, C.J., Fruehauf, J.H., Development of a therapeutic RNAi delivery system using nonpathogenic bacteria expressing inv and hly: transkingdom RNA interference (tkRNAi). Hum. Gene Ther., 20, 2009, 670.
-
(2009)
Hum. Gene Ther.
, vol.20
, pp. 670
-
-
Grillot-Courvalin, C.1
Goussard, S.2
Courvalin, P.3
Silva, A.4
Bodyak, N.5
Vaze, M.6
Sauer, N.7
Laroux, F.S.8
Harborth, J.9
Xiang, S.10
Li, C.J.11
Fruehauf, J.H.12
-
268
-
-
47649087754
-
Oral delivery of Lactobacillus casei Shirota modifies allergen-induced immune responses in allergic rhinitis
-
[268] Ivory, K., Chambers, S.J., Pin, C., Prieto, E., Arques, J.L., Nicoletti, C., Oral delivery of Lactobacillus casei Shirota modifies allergen-induced immune responses in allergic rhinitis. Clin. Exp. Allergy 38 (2008), 1282–1289.
-
(2008)
Clin. Exp. Allergy
, vol.38
, pp. 1282-1289
-
-
Ivory, K.1
Chambers, S.J.2
Pin, C.3
Prieto, E.4
Arques, J.L.5
Nicoletti, C.6
-
269
-
-
84879549202
-
Encapsulation of probiotic bacteria in biopolymeric system
-
[269] Huq, T., Khan, A., Khan, R.A., Riedl, B., Lacroix, M., Encapsulation of probiotic bacteria in biopolymeric system. Crit. Rev. Food Sci. Nutr. 53 (2013), 909–916.
-
(2013)
Crit. Rev. Food Sci. Nutr.
, vol.53
, pp. 909-916
-
-
Huq, T.1
Khan, A.2
Khan, R.A.3
Riedl, B.4
Lacroix, M.5
-
270
-
-
79951556308
-
Survivability of probiotics encapsulated in alginate gel microbeads using a novel impinging aerosols method
-
[270] Sohail, A., Turner, M.S., Coombes, A., Bostrom, T., Bhandari, B., Survivability of probiotics encapsulated in alginate gel microbeads using a novel impinging aerosols method. Int. J. Food Microbiol. 145 (2011), 162–168.
-
(2011)
Int. J. Food Microbiol.
, vol.145
, pp. 162-168
-
-
Sohail, A.1
Turner, M.S.2
Coombes, A.3
Bostrom, T.4
Bhandari, B.5
-
271
-
-
36549070569
-
Live encapsulated Lactobacillus acidophilus cells in yogurt for therapeutic oral delivery: preparation and in vitro analysis of alginate-chitosan microcapsules
-
[271] Urbanska, A.M., Bhathena, J., Prakash, S., Live encapsulated Lactobacillus acidophilus cells in yogurt for therapeutic oral delivery: preparation and in vitro analysis of alginate-chitosan microcapsules. Can. J. Physiol. Pharmacol. 85 (2007), 884–893.
-
(2007)
Can. J. Physiol. Pharmacol.
, vol.85
, pp. 884-893
-
-
Urbanska, A.M.1
Bhathena, J.2
Prakash, S.3
-
272
-
-
84912532659
-
Oral delivery of probiotic expressing M cell homing peptide conjugated BmpB vaccine encapsulated into alginate/chitosan/alginate microcapsules
-
[272] Jiang, T., Singh, B., Maharjan, S., Li, H.S., Kang, S.K., Bok, J.D., Cho, C.S., Choi, Y.J., Oral delivery of probiotic expressing M cell homing peptide conjugated BmpB vaccine encapsulated into alginate/chitosan/alginate microcapsules. Eur. J. Pharm. Biopharm. 88 (2014), 768–777.
-
(2014)
Eur. J. Pharm. Biopharm.
, vol.88
, pp. 768-777
-
-
Jiang, T.1
Singh, B.2
Maharjan, S.3
Li, H.S.4
Kang, S.K.5
Bok, J.D.6
Cho, C.S.7
Choi, Y.J.8
-
273
-
-
84899512686
-
Novel intestinal-targeted Ca-alginate-based carrier for pH-responsive protection and release of lactic acid bacteria
-
[273] Mei, L., He, F., Zhou, R.Q., Wu, C.D., Liang, R., Xie, R., Ju, X.J., Wang, W., Chu, L.Y., Novel intestinal-targeted Ca-alginate-based carrier for pH-responsive protection and release of lactic acid bacteria. ACS Appl. Mater. Interfaces 6 (2014), 5962–5970.
-
(2014)
ACS Appl. Mater. Interfaces
, vol.6
, pp. 5962-5970
-
-
Mei, L.1
He, F.2
Zhou, R.Q.3
Wu, C.D.4
Liang, R.5
Xie, R.6
Ju, X.J.7
Wang, W.8
Chu, L.Y.9
-
274
-
-
84876584594
-
Layer-by-layer coating of alginate matrices with chitosan-alginate for the improved survival and targeted delivery of probiotic bacteria after oral administration
-
[274] Cook, M.T., Tzortzis, G., Khutoryanskiy, V.V., Charalampopoulos, D., Layer-by-layer coating of alginate matrices with chitosan-alginate for the improved survival and targeted delivery of probiotic bacteria after oral administration. J. Mater. Chem. B 1 (2013), 52–60.
-
(2013)
J. Mater. Chem. B
, vol.1
, pp. 52-60
-
-
Cook, M.T.1
Tzortzis, G.2
Khutoryanskiy, V.V.3
Charalampopoulos, D.4
-
275
-
-
47149098240
-
In vitro and in vivo characterization of alginate-chitosan-alginate artificial microcapsules for therapeutic oral delivery of live bacterial cells
-
[275] Lin, J.Z., Yu, W.T., Liu, X.D., Xie, H.G., Wang, W., Ma, X.J., In vitro and in vivo characterization of alginate-chitosan-alginate artificial microcapsules for therapeutic oral delivery of live bacterial cells. J. Biosci. Bioeng. 105 (2008), 660–665.
-
(2008)
J. Biosci. Bioeng.
, vol.105
, pp. 660-665
-
-
Lin, J.Z.1
Yu, W.T.2
Liu, X.D.3
Xie, H.G.4
Wang, W.5
Ma, X.J.6
-
276
-
-
84930153477
-
Programmable probiotics for detection of cancer in urine
-
[276] Danino, T., Prindle, A., Kwong, G.A., Skalak, M., Li, H., Allen, K., Hasty, J., Bhatia, S.N., Programmable probiotics for detection of cancer in urine. Sci. Transl. Med., 7, 2015.
-
(2015)
Sci. Transl. Med.
, vol.7
-
-
Danino, T.1
Prindle, A.2
Kwong, G.A.3
Skalak, M.4
Li, H.5
Allen, K.6
Hasty, J.7
Bhatia, S.N.8
-
277
-
-
0034475164
-
Tumor-targeted Salmonella: highly selective delivery vectors
-
[277] Bermudes, D., Low, B., Pawelek, J., Tumor-targeted Salmonella: highly selective delivery vectors. Adv. Exp. Med. Biol., 2000, 57–63.
-
(2000)
Adv. Exp. Med. Biol.
, pp. 57-63
-
-
Bermudes, D.1
Low, B.2
Pawelek, J.3
-
278
-
-
84863100717
-
Bioengineered microbes in disease therapy
-
[278] Paton, A.W., Morona, R., Paton, J.C., Bioengineered microbes in disease therapy. Trends Mol. Med. 18 (2012), 417–425.
-
(2012)
Trends Mol. Med.
, vol.18
, pp. 417-425
-
-
Paton, A.W.1
Morona, R.2
Paton, J.C.3
-
279
-
-
84856271722
-
Engineering bacteria toward tumor targeting for cancer treatment: current state and perspectives
-
[279] Lee, C.H., Engineering bacteria toward tumor targeting for cancer treatment: current state and perspectives. Appl. Microbiol. Biotechnol. 93 (2012), 517–523.
-
(2012)
Appl. Microbiol. Biotechnol.
, vol.93
, pp. 517-523
-
-
Lee, C.H.1
-
280
-
-
84865981346
-
Bacteria-mediated in vivo delivery of quantum dots into solid tumor
-
[280] Liu, Y., Zhou, M., Luo, D., Wang, L.J., Hong, Y.K., Yang, Y.P., Sha, Y.L., Bacteria-mediated in vivo delivery of quantum dots into solid tumor. Biochem. Biophys. Res. Commun. 425 (2012), 769–774.
-
(2012)
Biochem. Biophys. Res. Commun.
, vol.425
, pp. 769-774
-
-
Liu, Y.1
Zhou, M.2
Luo, D.3
Wang, L.J.4
Hong, Y.K.5
Yang, Y.P.6
Sha, Y.L.7
-
281
-
-
79959380538
-
In tumors Salmonella migrate away from vasculature toward the transition zone and induce apoptosis
-
[281] Ganai, S., Arenas, R.B., Sauer, J.P., Bentley, B., Forbes, N.S., In tumors Salmonella migrate away from vasculature toward the transition zone and induce apoptosis. Cancer Gene Ther. 18 (2011), 457–466.
-
(2011)
Cancer Gene Ther.
, vol.18
, pp. 457-466
-
-
Ganai, S.1
Arenas, R.B.2
Sauer, J.P.3
Bentley, B.4
Forbes, N.S.5
-
282
-
-
49449116738
-
Inhibition of tumor growth using Salmonella expressing Fas ligand
-
[282] Loeffler, M., Le'Negrate, G., Krajewska, M., Reed, J.C., Inhibition of tumor growth using Salmonella expressing Fas ligand. J. Natl. Cancer Inst. 100 (2008), 1113–1116.
-
(2008)
J. Natl. Cancer Inst.
, vol.100
, pp. 1113-1116
-
-
Loeffler, M.1
Le'Negrate, G.2
Krajewska, M.3
Reed, J.C.4
-
283
-
-
78449281712
-
Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer
-
[283] Yam, C., Zhao, M., Hayashi, K., Ma, H.Y., Kishimoto, H., McElroy, M., Bouvet, M., Hoffman, R.M., Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer. J. Surg. Res. 164 (2010), 248–255.
-
(2010)
J. Surg. Res.
, vol.164
, pp. 248-255
-
-
Yam, C.1
Zhao, M.2
Hayashi, K.3
Ma, H.Y.4
Kishimoto, H.5
McElroy, M.6
Bouvet, M.7
Hoffman, R.M.8
-
284
-
-
57349194204
-
Primary activation of antigen-specific naive CD4(+) and CD8(+) T cells following intranasal vaccination with recombinant bacteria
-
[284] Ciabattini, A., Pettini, E., Andersen, P., Pozzi, G., Medaglini, D., Primary activation of antigen-specific naive CD4(+) and CD8(+) T cells following intranasal vaccination with recombinant bacteria. Infect. Immun. 76 (2008), 5817–5825.
-
(2008)
Infect. Immun.
, vol.76
, pp. 5817-5825
-
-
Ciabattini, A.1
Pettini, E.2
Andersen, P.3
Pozzi, G.4
Medaglini, D.5
-
285
-
-
47149091261
-
Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA
-
[285] Ciabattini, A., Giomarelli, B., Parigi, R., Chiavolini, D., Pettini, E., Arico, B., Giuliani, M.M., Santini, L., Medaglini, D., Pozzi, G., Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA. Vaccine 26 (2008), 4244–4250.
-
(2008)
Vaccine
, vol.26
, pp. 4244-4250
-
-
Ciabattini, A.1
Giomarelli, B.2
Parigi, R.3
Chiavolini, D.4
Pettini, E.5
Arico, B.6
Giuliani, M.M.7
Santini, L.8
Medaglini, D.9
Pozzi, G.10
-
286
-
-
77955924609
-
Effect of intranasal administration of Lactobacillus pentosus S-PT84 on influenza virus infection in mice
-
[286] Izumo, T., Maekawa, T., Ida, M., Noguchi, A., Kitagawa, Y., Shibata, H., Yasui, H., Kiso, Y., Effect of intranasal administration of Lactobacillus pentosus S-PT84 on influenza virus infection in mice. Int. Immunopharmacol. 10 (2010), 1101–1106.
-
(2010)
Int. Immunopharmacol.
, vol.10
, pp. 1101-1106
-
-
Izumo, T.1
Maekawa, T.2
Ida, M.3
Noguchi, A.4
Kitagawa, Y.5
Shibata, H.6
Yasui, H.7
Kiso, Y.8
-
287
-
-
84928559047
-
Effect of histolyticus infection and toxin on transplantable mouse tumors
-
[287] Parker, R.C., Plummber, H.C., Siebenmann, C.O., Chapman, M.G., Effect of histolyticus infection and toxin on transplantable mouse tumors. Proc. Soc. Exp. Biol. Med. 66 (1947), 461–465.
-
(1947)
Proc. Soc. Exp. Biol. Med.
, vol.66
, pp. 461-465
-
-
Parker, R.C.1
Plummber, H.C.2
Siebenmann, C.O.3
Chapman, M.G.4
-
288
-
-
78651152166
-
Oncolysis by clostridia. III. Effects of clostridia
-
[288] Thiele, E.H., Arison, R.N., Boxer, G.E., Oncolysis by clostridia. III. Effects of clostridia. Cancer Res. 24 (1964), 222–233.
-
(1964)
Cancer Res.
, vol.24
, pp. 222-233
-
-
Thiele, E.H.1
Arison, R.N.2
Boxer, G.E.3
-
289
-
-
0000775441
-
Oncolysis by Clostridia. I. Activity of Clostridium butyricum (M-55) and other nonpathogenic clostridia against the Ehrlich carcinoma
-
[289] Möse, J.R., Möse, G., Oncolysis by Clostridia. I. Activity of Clostridium butyricum (M-55) and other nonpathogenic clostridia against the Ehrlich carcinoma. Cancer Res. 24 (1964), 212–216.
-
(1964)
Cancer Res.
, vol.24
, pp. 212-216
-
-
Möse, J.R.1
Möse, G.2
-
290
-
-
0030888162
-
Function of the Escherichia coli msbB gene, a multicopy suppressor of htrB knockouts, in the acylation of lipid A. Acylation by MsbB follows laurate incorporation by HtrB
-
[290] Clementz, T., Zhou, Z., Raetz, C.R.H., Function of the Escherichia coli msbB gene, a multicopy suppressor of htrB knockouts, in the acylation of lipid A. Acylation by MsbB follows laurate incorporation by HtrB. J. Biol. Chem. 272 (1997), 10353–10360.
-
(1997)
J. Biol. Chem.
, vol.272
, pp. 10353-10360
-
-
Clementz, T.1
Zhou, Z.2
Raetz, C.R.H.3
-
291
-
-
0034838233
-
Extragenic suppressors of growth defects in msbB Salmonella
-
[291] Murray, S.R., Bermudes, D., De Felipe, K.S., Low, K.B., Extragenic suppressors of growth defects in msbB Salmonella. J. Bacteriol. 183 (2001), 5554–5561.
-
(2001)
J. Bacteriol.
, vol.183
, pp. 5554-5561
-
-
Murray, S.R.1
Bermudes, D.2
De Felipe, K.S.3
Low, K.B.4
-
292
-
-
0141653956
-
Bacteria as tumour-targeting vectors
-
[292] Pawelek, J.M., Low, K.B., Bermudes, D., Bacteria as tumour-targeting vectors. Lancet Oncol. 4 (2003), 548–556.
-
(2003)
Lancet Oncol.
, vol.4
, pp. 548-556
-
-
Pawelek, J.M.1
Low, K.B.2
Bermudes, D.3
-
293
-
-
84875966999
-
Cell-based therapeutics: the next pillar of medicine
-
[293] Fischbach, M.A., Bluestone, J.A., Lim, W.A., Cell-based therapeutics: the next pillar of medicine. Sci. Transl. Med. 5 (2013), 177–179.
-
(2013)
Sci. Transl. Med.
, vol.5
, pp. 177-179
-
-
Fischbach, M.A.1
Bluestone, J.A.2
Lim, W.A.3
-
294
-
-
34547612220
-
Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement
-
[294] Brandau, S., Suttmann, H., Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement. Biomed. Pharmacother. 61 (2007), 299–305.
-
(2007)
Biomed. Pharmacother.
, vol.61
, pp. 299-305
-
-
Brandau, S.1
Suttmann, H.2
-
295
-
-
84955192252
-
'Deadman' and 'Passcode' microbial kill switches for bacterial containment
-
[295] Chan, C.T.Y., Lee, J.W., Cameron, D.E., Bashor, C.J., Collins, J.J., 'Deadman' and 'Passcode' microbial kill switches for bacterial containment. Nat. Chem. Biol. 12:2 (2016), 82–86.
-
(2016)
Nat. Chem. Biol.
, vol.12
, Issue.2
, pp. 82-86
-
-
Chan, C.T.Y.1
Lee, J.W.2
Cameron, D.E.3
Bashor, C.J.4
Collins, J.J.5
-
296
-
-
36749028153
-
A wall of funnels concentrates swimming bacteria
-
[296] Galajda, P., Keymer, J., Chaikin, P., Austin, R., A wall of funnels concentrates swimming bacteria. J. Bacteriol. 189 (2007), 8704–8707.
-
(2007)
J. Bacteriol.
, vol.189
, pp. 8704-8707
-
-
Galajda, P.1
Keymer, J.2
Chaikin, P.3
Austin, R.4
-
297
-
-
34547419779
-
Self-motile colloidal particles: from directed propulsion to random walk
-
[297] Howse, J.R., Jones, R.A., Ryan, A.J., Gough, T., Vafabakhsh, R., Golestanian, R., Self-motile colloidal particles: from directed propulsion to random walk. Phys. Rev. Lett., 99, 2007, 048102.
-
(2007)
Phys. Rev. Lett.
, vol.99
, pp. 048102
-
-
Howse, J.R.1
Jones, R.A.2
Ryan, A.J.3
Gough, T.4
Vafabakhsh, R.5
Golestanian, R.6
-
298
-
-
0344702705
-
Influence of topology on bacterial social interaction
-
[298] Park, S., Wolanin, P.M., Yuzbashyan, E.A., Lin, H., Darnton, N.C., Stock, J.B., Silberzan, P., Austin, R., Influence of topology on bacterial social interaction. Proc. Natl. Acad. Sci. 100 (2003), 13910–13915.
-
(2003)
Proc. Natl. Acad. Sci.
, vol.100
, pp. 13910-13915
-
-
Park, S.1
Wolanin, P.M.2
Yuzbashyan, E.A.3
Lin, H.4
Darnton, N.C.5
Stock, J.B.6
Silberzan, P.7
Austin, R.8
-
299
-
-
84885456965
-
Targeted delivery of colloids by swimming bacteria
-
2588
-
[299] Koumakis, N., Lepore, A., Maggi, C., Di Leonardo, R., Targeted delivery of colloids by swimming bacteria. Nat. Commun., 4, 2013, 2588.
-
(2013)
Nat. Commun.
, vol.4
-
-
Koumakis, N.1
Lepore, A.2
Maggi, C.3
Di Leonardo, R.4
-
300
-
-
84875262894
-
Microbial ecosystems therapeutics: a new paradigm in medicine?
-
[300] Petrof, E.O., Claud, E.C., Gloor, G.B., Allen-Vercoe, E., Microbial ecosystems therapeutics: a new paradigm in medicine?. Benefic. Microbes 4 (2013), 53–65.
-
(2013)
Benefic. Microbes
, vol.4
, pp. 53-65
-
-
Petrof, E.O.1
Claud, E.C.2
Gloor, G.B.3
Allen-Vercoe, E.4
-
301
-
-
84905080906
-
Microbiome therapy gains market traction
-
[301] Reardon, S., Microbiome therapy gains market traction. Nature 509 (2014), 269–270.
-
(2014)
Nature
, vol.509
, pp. 269-270
-
-
Reardon, S.1
-
302
-
-
7444253428
-
Systems biology and new technologies enable predictive and preventative medicine
-
[302] Hood, L., Heath, J.R., Phelps, M.E., Lin, B., Systems biology and new technologies enable predictive and preventative medicine. Science 306 (2004), 640–643.
-
(2004)
Science
, vol.306
, pp. 640-643
-
-
Hood, L.1
Heath, J.R.2
Phelps, M.E.3
Lin, B.4
|